bibliography - inflibnetshodhganga.inflibnet.ac.in/bitstream/10603/4770/13/13_bibliography.pdf ·...

46
Bibliography Abel, E.D., 2004. Glucose transport in the heart. Frontiers in Bioscience 9, 201– 215. ADA: Clinical practice recommendation 1997, Screening for diabetes. Diabetes care 20(1), 22-24. Affourtit, C., Brand, M.D., 2006. Stronger control of ATP/ADP by proton leak in pancreatic beta-cells than skeletal muscle mitochondria. The Biochemical Journal 393, 151–159. Agrawal, P., Rai, V., Singh, RB., 1996. Randomized placebo-controlled, single blind trial of holy basil leaves in patients with noninsulin-dependent diabetes mellitus. International Journal of Clinical Pharmacology and Therapeutics 34(9), 406–409. Agullo, G., Gamet–Payrastre, L., Manenti, S., Viala, C., Rmsy, C., Chap, H., Payrastre, B., 1997. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition., Biochemical Pharmacology 53, 1649–1657. Aherne, S.A., O’Brien, N.M., 2002. Dietary flavonols: chemistry, food content, and metabolism., Nutrition 18, 75–81. Ahlawat, R., Sahi, R.P., Agarwal, P.K., 1985. Histological changes in pancreas after experimentally produced duodenal obstruction in Charles Foster rats. Indian Journal of Experimental Biology 23(10), 596–599. Ahmed, S.M., Vrushabendra, S.B.M., Gopkumar, P., Dhanapal, R., Chandrashekara, V.M., 2005. Anti-Diabetic activity of Terminalia catappa Linn. Leaf extracts in alloxan–induced diabetic rats. Iranian Journal of Pharmacology and Therapeutics 4, 36–39. Alarcon-Aguilara, F.J., Roman-Ramos, R., Perez-Gutierrez, S., Aguilar-Contreras, A., Contreas-Weber, C.C., Flores-Saenz, J.L., 1998. Study of the antihyperglycemic effect of plants used as antidiabetics. Journal of Ethnopharmacology 61, 101–110. Al-Azzawie, H.F., Alhamdani, M.S., 2006. Hypoglycemic and antioxidant effect of oleuropein in alloxan-diabetic rabbits . Life Sciences 78, 1371–1377.

Upload: doandung

Post on 16-May-2018

216 views

Category:

Documents


2 download

TRANSCRIPT

Bibliography

Abel, E.D., 2004. Glucose transport in the heart. Frontiers in Bioscience 9,

201– 215.

ADA: Clinical practice recommendation 1997, Screening for diabetes.

Diabetes care 20(1), 22-24.

Affourtit, C., Brand, M.D., 2006. Stronger control of ATP/ADP by proton

leak in pancreatic beta-cells than skeletal muscle mitochondria. The

Biochemical Journal 393, 151–159.

Agrawal, P., Rai, V., Singh, RB., 1996. Randomized placebo-controlled,

single blind trial of holy basil leaves in patients with

noninsulin-dependent diabetes mellitus. International Journal of

Clinical Pharmacology and Therapeutics 34(9), 406–409.

Agullo, G., Gamet–Payrastre, L., Manenti, S., Viala, C., Rmsy, C., Chap,

H., Payrastre, B., 1997. Relationship between flavonoid structure and

inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine

kinase and protein kinase C inhibition., Biochemical Pharmacology 53,

1649–1657.

Aherne, S.A., O’Brien, N.M., 2002. Dietary flavonols: chemistry, food

content, and metabolism., Nutrition 18, 75–81.

Ahlawat, R., Sahi, R.P., Agarwal, P.K., 1985. Histological changes in

pancreas after experimentally produced duodenal obstruction in Charles

Foster rats. Indian Journal of Experimental Biology 23(10), 596–599.

Ahmed, S.M., Vrushabendra, S.B.M., Gopkumar, P., Dhanapal, R.,

Chandrashekara, V.M., 2005. Anti-Diabetic activity of Terminalia

catappa Linn. Leaf extracts in alloxan–induced diabetic rats. Iranian

Journal of Pharmacology and Therapeutics 4, 36–39.

Alarcon-Aguilara, F.J., Roman-Ramos, R., Perez-Gutierrez, S.,

Aguilar-Contreras, A., Contreas-Weber, C.C., Flores-Saenz, J.L., 1998.

Study of the antihyperglycemic effect of plants used as antidiabetics.

Journal of Ethnopharmacology 61, 101–110.

Al-Azzawie, H.F., Alhamdani, M.S., 2006. Hypoglycemic and antioxidant

effect of oleuropein in alloxan-diabetic rabbits . Life Sciences 78,

1371–1377.

Alberti, K.G., Zimmet, P.Z., 1998. New diagnostic criteria and classification

of diabetes - again ? Diabetic Medicine 15, 535–536.

Allen, D.W., 1964. Hemogolobin within the red cell. Academic Press, New

York and London.

Almdal, J.P., Vilstrup, H., 1988. Strict insulin therapy normalizes organ

nitrogen contents and the capacity of urea nitrogen synthesis in

experimental diabetes in rats, Diabetologia 31, 114–118.

Al–Yassin, D., Ibrahim, K., 1981. A minor haemoglobin fraction and the

level of fasting blood glucose. Journal of Faculty of Medicine University

of Baghdad 23, 373–380.

Anam, K., Widharma, R.H., Kusrini, D., 2009. α-Glucosidase inhibitor

activity of Terminalia species. International Journal of Pharmacology 54,

277–280.

Anand, K.K., Singh, B., Saxena, A.K., Chandan, B.K., Gupta, V.N., 1994.

Hepatoprotective studies of a fraction from the fruits of Terminalia

bellerica on experimental liver injury in rodents. Phytotherapy Research

8, 287–292.

Anand, K.K., Singh, B., Saxena, A.K., Chandan, B.K., Gupta, V.N.,

Bhardwaj V., 1997. 3,4,5-Trihydroxy benzoic acid (gallic acid), the

hepatoprotective principle in the fruits of Terminalia bellerica-bioassay

guided activity, Pharmacological Research 36 315–321.

Anderson, R.A., Polansky M.M., Tea enhances insulin activity., Journal of

Agricultural and Food Chemistry 50, 7182–7186.

Anjana J., Monika B., Sangeeta S., 2007. Protective effect of Terminalia

bellerica Roxb. and gallic acid against carbon tetrachloride induced

damage in albino rats, Journal of Ethnopharmacology 109, 214–218.

Anuradha, K., Hota, D., Pandhi, P., 2004. Investigation of Central

mechanism of Insulin induced hypoglycemic convulsions in mice. Indian

Journal of Experimental Biology 42, 368–372.

Anuradha, C.V., Selvam, R., 1993. Effect of oral methionine on tissue lipid

peroxidation and antioxidants in alloxan-induced diabetic rats. Journal

of Nutritional Biochemistr 4, 212–217.

Arif-ullah Khan, Anwarul Hassan Gilani, 2008. Pharmacodynamic

Evaluation of Terminalia bellerica for Its Antihypertensive Effect.

Journal of Food and Drug Analysis 16(3), 6–14.

Ashizawa, N., Endoh, H., Hidaka, K., Watanabe, M. and Fukumoto, S.,

1997. Three-dimensional structure of the rat pancreatic duct in normal

and inflammated pancreas. Microscopy Research and Technique 37,

543–556.

Aslan, M., Orhan, D.D., Orhan, N., 2007. In vivo antidiabetic and

antioxidant potential of Helichrysum plicatum ssp. plicatum capitulums

in streptozotocin-induced-diabetic rats. Journal of Ethnopharmacology

109(1), 54–59.

Auger, C., Caporiccio, B., Landrault, N., Teissedre, P.L., Laurent,

C., Cros, G., Besanon, P., Rouanet, J.M., 2002. Red wine phenolic

compounds reduce plasma lipids and apolipoprotein B and prevent early

aortic atherosclerosis in hyper cholesterolemic golden Syrian hamsters

(Mesocricetus auratus). Journal of Nutrition 132, 1207–1213.

Aurell, M., Bjorck, S., 1992. Determination of progressive renal disease in

diabetes mellitus. Kidney International 41, 38–42.

Baginsky, E.S., Foa, P.P., Zak, B., 1992. Methods of enzymatic analysis. Vol

2, Second edition, Bergmeyer HU and Gawehn K edition, Academic Press,

New York.

Bahulikar, A.S., Kashalkar, R.V., Pundlik, M.D., 2003. HPLC in

standardization of herbal drugs: studies on Triphala powder. Asian

Journal of Chemistry 15, 229–234.

Bailey, C.J., 1992. Biguanides and NIDDM. Diabetes Care 15, 755–772.

Bailey, C.J., Day, C., 1989. Traditional plant medicines as treatment for

diabetes. Diabetes Care 12, 553–564.

Bajaj, M., DeFronzo, R.A., 2003. Metabolic and molecular basis of insulin

resistance. Journal of Nuclear Cardiology 10(3), 311–323.

Bajpai, M., Pande, A., Tewari S.K., Prakash, D., 2005. Phenolic contents

and antioxidant activity of some food and medicinal plants. International

Journal of Food Sciences & Nutrition 56, 287–291.

Bakris, G.L., Diabetic nephropathy, 1997. What you need to know to

preserve kidney function. Postgraduate Medicine 93, 89.

Balfour J.A., McTavish D., 1993. Acarbose: an update of its pharmacology

and therapeutic use in diabetes mellitus. Drugs 46, 1025–1054.

Banting, F., and C. Best. 1922. The internal secretion of the pancreas.

Journal of Laboratory and Clinical Medicine 7, 251–266.

Barla, F., Higashijima, H., Funai, S., Sugimoto, K., Harada, N., Yamaji,

R., Fujita, T., Nakano, Y., Inui, H., 2009. Inhibitive effects of alkyl

gallates on hyaluronidase and collagenase. Bioscience, Biotechnology,

and Biochemistry 73(10), 2335–2337.

Baynes, J.W., Thorpe, S.R., 1999. Role of oxidative stress in diabetic

complications:a new perspective on an old paradigm. Diabetes 48, 1–9.

Beaven, S.W., Tontonoz, P., 2006. Nuclear receptors in lipid metabolism:

targeting the heart of dyslipidemia., Annual Review of Medicine 57,

313–329.

Bedoya F.J., Solano, F., Lucas, M., 1996. N-monomethyl-arginine and

nicotinamide prevent streptozotocin-induced double strand DNA break

formation in pancreatic rat islets. Experientia 52, 344–347.

Bentley, G. A., Dodson, E.J., Dodson, G.G., Hodgkin, D.C., Mercola, D.,

1976. Structure of insulin in 4-zinc insulin. Nature 261, 166–168.

Berger, J., Biswas, C., Vicario, P.P., Strout, H.V., Saperstein, R., Pilch, P.F.,

1989. Decreased expression of the insulin-responsive glucose transporter

in diabetes and fasting. Nature. 340(6228), 70–72.

Berger J., Moller D.E., 2002. The mechanisms of action of PPARs. Annual

Review of Medicine 53, 409–435.

Bevan, P., 2001. Insulin signalling. Journal of Cell Science 114(8),

1429–1430.

Beyer-Mears A., Cruz E., 1985. Reversal of diabetic cataract by sorbinil, an

aldose reductase inhibitor. Diabetes 34, 15–21.

Bhavapriya, V., Kalpana, S., Govindasamy, S., Apparanantham, T.. 2001.

Biochemical studies on hypoglycemic effect of Aavirai kudineer: a herbal

formulation in alloxan diabetic rats. Indian Journal of Experimental

Biology 39, 925–928.

Birnbaum, M.J., 1989. Identification of a novel gene encoding an insulin

responsive glucose transporter protein. Cell 57, 305–315.

Bishop–Bailey, D., Wray, J., 2003. Peroxisome proliferator-activated

receptors: a critical review on endogenous pathways for ligand

generation. Prostaglandins Other Lipid Mediators 71, 1–22.

Bliss, M., 2000. The Discovery of Insulin. University of Chicago Press,

Chicago,USA, 321–1418.

Bloomgarden, Z.T., 2008. Approaches to Treatment of Type 2 Diabetes.

Diabetes Care 31(8), 1697–1703.

Blundell, T.L., Dodson, G.G., Hodgkin, D.C., Mercola, D., 1972. Insulin:

The structure in the crystal and its reflection in chemistry and biology.

Advances in Protein Chemistry 26, 279–402.

Bnouham, M., Ziyyat, A., Mekhfi, H., Tahri, A., Legssyer, A., 2006.

Medicinal plants with potential antidiabetic activity - A review of ten

years of herbal medicine research (1990–2000). International Journal of

Diabetes and Metabolism 14, 1–25.

Bolaffi, J.L., Nagamatsu, S., Harris, J., Grodsky, G.M., 1987. Protection

by thymidine, an inhibitor of polyadenosine diphosphate ribosylation,

of streptozotocin inhibition of insulin secretion. Endocrinology 120,

2117–2122.

Bolkent, R., Yanarda, A., Tabakolu-Ouz O., Ozsoy-Sacan, 2000. Effect

of Chard (Beta vulgaris L. Var. Cida) extract on pancreatic B cells in

Streptozotocin -Diabetic Rats: a Morphological and Biochemical Study.

Journal of Ethanopharmacology 73(1–2), 251–259.

Bonkovsky, H.L., Azar, R., Bird, S., Szabo, G., Banner, B., 2002. Severe

cholestatic hepatitis caused by thiazolidinediones: risks associated

with substituting rosiglitazone for troglitazone. Digestive Disease and

Sciences. 47(7), 1632–1637.

Bonner-Weir, S., 2000. Islet growth and development in the adult. Journal

of Molecular Endocrinology 24, 297–302.

Boon, N.A., Colledge, N.R., Walker, B.R., Hunter, J.A.A., (eds), 2006.

Davidson’s Principles and Practice of Medicine, 20th edition, Churchill

Livingstone-Elsevier Publishers, Philadelphia, 843–844.

Bora, P.S., Srivastava, L.M., Bhatt, S.D., 1985. Metabolic and

histopathological effects of streptozotocin induced diabetes in rats: effect

of propranolol and insulin. Indian Journal of Experimental Biology 23,

23–26.

Bose, M., Lambert, J.D., Ju, J., Reuhl, K.R., Shapses, S.A., Yang, C.S., 2008.

The Major Green Tea Polyphenol, (–)-Epigallocatechin-3-Gallate, Inhibits

Obesity, Metabolic Syndrome, and Fatty Liver Disease in High-Fat-Fed

Mice. Journal of Nutrition 138(9), 1677–1683.

Boulton, A.J.M., Ward, J.D., 1986. Diabetic neuropathies and pain. Clinical

Endocrinology and Metabolism 15, 917.

Boynes, J.W., 1991. Role of oxidative stress in the development of

complication in diabetes. Diabetes 40, 405-411.

Brandstrup, N., Kirk, J.E., Bruni, C., 1957. The hexokinase and

phosphoglucoisomerase activities of aortic and pulmonary artery tissue

in individuals of various ages. Journal of Gerontology 12, 166–170.

Brange, J., Ribel, U., Hansen, J.F., Dodson, G., Hansen, M.T., Havelund,

S., Melberg, S.G., Norris, F., Norris, K., Snel, L., Sorensen, A.R., Voigt,

H.O., 1988. Monomeric insulins obtained by protein engineering and

their medical implications. Nature 333, 679–682.

Braunlich, H., Marx, F., Fleck, C., Stein, G., 1997. Kidney function in

rats after 5/6 nephrectomy; effort of treatment with vitamin E. Journal

Experimental and Toxicologic Pathology 49, 135–139.

Brownlee, M., 1995. Advanced protein glycosylation in diabetes and aging.

Annual Review of Medicine 46, 223–234.

Bunn, H.F., 1981. Evaluation of glycosylated hemoglobin in diabetic

patients. Diabetes, 30, 613–617.

Bunn, H.F., Gabbay, K.H., Gallop, P.M., 1978. The glycosylation of

hemoglobin: relevance to diabetes mellitus. Science 200, 2l–27.

Bunn, H.F., Haney, D.N., Kamin, S., Gabbay, K.H., Gallop, P.M., 1976. The

biosynthesis of human hemoglobin A1c. Slow glycosylation of hemoglobin

in vivo. Journal of Clinical Investigation 57(6), 1652–1659.

Burtis, C.A., Ashwood, E.R., 1996. Tietz: Fundamentals of Clinical

Chemistry, 4th Edition, W.B. Saunders, Philadelphia (PA) 312–335.

Butler, A.E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R.A., Butler, P.C.,

2003. Beta-Cell Deficit and Increased Beta-Cell Apoptosis in Humans

With Type 2 Diabetes. Diabetes 52, 102–110.

Campbell, R.K., White Jr., J.R., 2002. Insulin therapy in type 2 diabetes.

Journal of the American Pharmaceutical Association 42(4), 602–611.

Cao, H., Hininger–Favier, I., Kelly, M.A., Benaraba, R., Dawson, H.D.,

Coves, S., Roussel, A.M., Anderson, R.A., 2007a. Green Tea Polyphenol

Extract Regulates the Expression of Genes Involved in Glucose Uptake

and Insulin Signaling in Rats Fed a High Fructose Diet. Journal of

agricultural and food chemistry 55(15), 6372–6378.

Cao, H., Polansky, M.M., Anderson, R.A., 2007b. Cinnamon extract and

polyphenols affect the expression of tristetraprolin, insulin receptor,

and glucose transporter 4 in mouse 3T3-L1 adipocytes. Archives of

Biochemistry and Biophysics 459(2), 214–222.

Caraway, W.T., 1955. Determination of uric acid in serum by carbonate

method. American Journal of Clinical Pathology 25(7), 840–845.

Carr, I., Rojers, C.B., 1986. Chemosystamatics studies of the genus

Combretum (Combretacece). I.A convenient method of identifying species

of this genus by a comparison of the polar constituents extracted from

leaf material. South African Journal of Botany 53, 173–176.

Cascn, E., Roig, R., Ardvol, A., Salvad, M.J., Arola, L., Blad, C.,

2001. Nonalcoholic components in wine reduce low density lipoprotein

cholesterol in normocholesterolemic rats., Lipids 36, 383–388.

Caumo, A., Florea, I., Luzi, L., 2007. Effect of a variable hepatic insulin

clearance on the postprandial insulin profile: insights from a model

simulation study. Acta Diabetologica 44(1), 23–29.

Cersosimo, E., Ajmal, M., Naukam, R.J., Molina, P.E., Abumrad,

N.N., 1997. Role of the kidney in plasma glucose regulation during

hyperglycemia. American Journal of Physiology 272, 756–761.

Chakravarthy, B.K., Gupta, S., Gambhir, S.S., Gode, K.D., 1980. Pancreatic

beta-cell regeneration A novel antidiabetic mechanism of Pterocarpus

marsupium Roxb. Indian Journal of Pharmacology 12(2), 123–127.

Chakravarthy, B.K., Gupta, S., Gambhir, S.S., Gode, K.D., 1981. Pancreatic

beta-cell regeneration in rats by (–)-epicatechin. Lancet 2, 759–760.

Chakravarthy, B.K., Gupta, S., Gode, K.D., 1982. Functional beta cell

regeneration in the islets of pancreas in alloxan induced diabetic rats

by (–)-epicatechin. Life Sciences 31, 2693–2697.

Chakravarti, M.D., Tayal, J.N., 1947. Preliminary examination of the fruits

of Terminalia belerica Roxb. Science Culture 13, 122–126.

Champe, P.C., Harvey, R.A., Ferrier, D.R., 2005. Biochemistry. Lippincott’s

Illustrated Reviews, Eds., Harvey, R.A. and P.C. Champe. New York:

Lippincott Williams and Wilkins, 305–318.

Chandramohan, G., Ignacimuthu, S., Pugalendi, K.V., 2008. A novel

compound from Casearia esculenta (Roxb.) root and its effect on

carbohydrate metabolism in streptozotocin-diabetic rats. European

Journal of Pharmacology 590(1–3), 437–443.

Chang, A.Y., 1972. Comparison of liver glycogen synthetase between

streptozotocin-diabetic and control rats. Canadian Journal of

Biochemistry 50(6), 714–717.

Charron, M. J., Katz, E. B., Olson, A. L., 1999. GLUT 4 gene regulation and

manipulation. Journal of Biological Chemistry 274(6), 3253–3256.

Chatterjea, M.N., Shinde, R., 2002. Text Book of Medical Biochemistry,

Jaypee Brothers Medical Publishers, New Delhi, 317.

Chattopadhyay, R.R., Bhattacharyya, S.K., 2007. PHCOG REV.: Plant

Review Terminalia chebula: An update, Pharmacognosy Reviews 1(1),

151–156.

Cheng, H.Y., Lin, T.C., Yu, K.H., Yang, C.M., Lin, C.C., 2003. Antioxidant

and free radical scavenging activities of Terminalia chebula. Biological &

Pharmaceutical Bulletin 26(9), 1331–1335.

Choi, K.C., Lee, Y.H., Jung, M.G., Kwon, S.H., Kim, M.J., Jun,

W.J., Lee, J., Lee, J.M., Yoon, H.G., 2009. Gallic acid suppresses

lipopolysaccharide-induced nuclear factor-kappaB signaling by

preventing RelA acetylation in A549 lung cancer cells. Molecular

Cancer Research 7(12), 2011–2021.

Chopra, R.N., Nayar, S.L., Chopra, I.C., 1996. Glossary of Indian Medicinal

Plants. C.S.I.R. publication, New Delhi, 241.

Collier, A., Wilson ,R., Bradley, H., Thomson, J.A., Small, M., 1990. Free

radical activity in type 2 diabetes. Diabetes 7, 27–30.

Cornblath, M., Randle, P.J., Parmeggiani, M., Morgan, H.E., 1963.

Regulation of glycogenolysis in muscle. Journal of Biological Chemistry

238, 1592.

Cuatrecasas, P., 1971. Insulin-receptor interactions in adipose tissue

cells: direct measurement and properties. Proceedings of the National

Academy of Sciences of the USA 68, 1264–1268.

Cushman, S.W., Wardzala, L.J., 1980. Potential mechanism of insulin

action on glucose transport in the isolated rat adipose cell. Apparent

translocation of intracellular transport systems to the plasma membrane.

Journal of Biological Chemistry 255, 4758–4762.

Czech, M., 1985. The nature and regulation of the insulin receptor:

Structure and Function. Annual Review of Physiology 47, 357–381.

Daisy, P., Sasikala, R., Ambika, A., 2009. Analysis of Binding Properties of

Phosphoinositide 3-kinase Through In silico Molecular Docking. Journal

of Proteomics and Bioinformatics 2(6), 274–284.

Daisy, P., Balasubramanian, K., Rajalakshmi, M., Eliza, J., Selvaraj, J.,

2010. Insulin mimetic impact of Catechin isolated from Cassia fistula on

the glucose oxidation and molecular mechanisms of glucose uptake on

Streptozotocin-induced diabetic Wistar rats. Phytomedicine 17, 28–36.

Das, A.V., Padayatti, P.S. and Paulose, C.S., 1996. Effect of leaf extract of

Aegle marmelose (L.) Correaex Roxb. on histological and ultrastructural

changes in tissues of streptozotocin induced diabetic rats. Indian Journal

of Experimental Biology 34, 341–345.

Das, K.C., Das, C.K., 2000. Thioredoxin, a singlet oxygen quencher and

hydroxyl radical scavenger: redox independent functions. Biochemical

and Biophysical Research Communications 277, 443–447.

Dash, R.J., 1999. Classification of diabetes mellitus. Current Medical

Journal-North Zone 6, 39–42.

Davie, S.J., Gould, B.J., Yudkin, J.S. 1992. Effect of vitamin C as

glycosylation of proteins. Diabetes 41, 167–169.

DCCT - The Diabetes Control and Complications Trial Research Group,

1993. The effect of intensive treatment of diabetes on the development

and progression of long-term complications in insulin-dependent diabetes

mellitus. New England Journal of Medicine 329, 977–986.

Defronzo, R.A., 1999. Pharmacologic therapy for type 2 diabetes mellitus.

Annals of Internal Medicine 13, 281–303.

Degirmenchi, I., Kalender, S., Ustuner, M. C., Kalender, Y., Gunes, H. V.,

Unal, N., Basaran, A., 2002. The effects of acarbose and Rumex patientia

on liver ultrastructure in streptozotocin-induced diabetic (type-II) rats.

Drugs under experimental and clinical research 28, 229–234.

De Meyts, P., Whittaker, J., 2002. Structural biology of insulin and IGF1

receptors: implications for drug design. Nature Reviews Drug Discovery

1, 769–783.

De Meyts, P., 2004. Insulin and its receptor: structure, function and

evolution. BioEssays 26, 1351–1362.

De Meyts, P., 2008. The insulin receptor: a prototype for dimeric, allosteric

membrane receptors. Trends in Biochemical Sciences 33, 376–384.

Derewenda, U., Derewenda, Z., Dodson, E.J., Dodson, G.G., Reynolds, C.D.,

Smith, G.D., Sparks, C., Sweson, D., 1989. Phenol stabilizes more helix

in a new symmetrical zinc insulin hexamer. Nature 338, 594–596.

Dey, B.B., Raman, S., 1957. Laboratory manual of organic chemistry. S.

Viswanathan Publication, Madras.

Dickinson, P.J., Carrington, A.L., Frost, G.S., Boulton, A.J.M.,

2002. Neurovascular disease, antioxidants and glycation in diabetes.

Diabetes/Metabolism Research and Reviews, 18, 260–272.

Dietrich, H., Rechner, A., Patz, C.D., 2004. Bioactive compounds in fruit

and juice. Fruit Process 1, 50–55.

Diller, D.J., Merz, K.M., Jr., 2001 High Throughput Docking for Library

Design and Library Prioritization. Proteins., 43, 113–124.

Doda, R.F., 1996. Diabetes mellitus. In: L.A. Kaplan, J.P. Amadeo, eds.

Clinical Chemistry, St Louis: Mosby Year Book, 613–641.

Dodson, G., Steiner, D., 1998. The role of assembly in insulin biosynthesis.

Current Opinion in Structural Biology 8, 189–194.

Dombrowski, L., Roy, D., Mareotte, B., Marette, A., 1996. A new procedure

for the isolation of plasma membrane, T-tubules and internal membranes

from skeletal muscles. American Journal of Physiology 270, 667676.

Drabkin, D.L., Austin, J.M., 1932. Spectrophotometric constants for

common haemoglobin derivatives in human, dog and rabbit blood.

Journal of Biological Chemistry 98, 719–733.

Drews, J. 2000. Drug discovery: A historical Perspective. Scinece 287,

1960–1964.

Dudly H Williams, Ian Fleming, 1989. Spectroscopic methods in Organic

Chemistry, Fourth Edition. Mc Graw–Hill Book Company, 29–62.

Dugani, C.B., Klip, A., 2005. Glucose transporter 4: cycling, compartments

and controversies. EMBO Reports 6, 1137–1142.

Duke J.A., Bogenschutz–Godwin M.J., Ducelliar J., Duke P.A.K., 2002.

Handbook of Medicinal Herbs, 2nd ed., Boca Raton, Florida, C R C Press

70–71.

Dunne, M.J., Cosgrove, K.E., Shepherd, R.M., Aynsley–Green, A., Lindley,

K.J., 2004. Hyperinsulinsm in infancy: from basic science to clinical

disease. Physiological Reviews 84, 239–275.

Eidi, A., Eidi, M., Esmaeili, E., 2006. Antidiabetic effect of garlic

(Allium sativum L.) in normal and streptozotocin-induced diabetic

rats. Phytomedicine:International Journal of Phytotherapy and

Phytopharmacology 13, 624–629.

El-Demerdash, F.M., Yousef, M.I., El-Naga, N.I., 2005. Biochemical study

on the hypoglycemic effects of onion and garlic in alloxan-induced

diabetic rats. Food and Chemical Toxicology 43(1), 57-63.

Ellman, G.L., 1959. Tissue sulfhydryl groups. Archives of Biochemistry and

Biophysics 82(1), 70–77.

Elsner, M., Guldbakke, B., Tiedge, M., Munday, R., Lenzen, S., 2000.

Relative importance of transport and alkylation for pancreatic beta-cell

toxicity of streptozotocin. Diabetologia 43, 1528–1533.

Ernst, E., 1997. Plants with hypoglycemic activity in humans.

Phytomedicine 4, 73-78.

Fang, X.K., Gao, J., Zhu, D.N., 2008. Kaempferol and quercetin isolated

from Euonymus alatus improve glucose uptake of 3T3-L1 cells without

adipogenesis activity. Life Sciences 82(11–12), 615–622.

Farnsworth, N.R., 1980. The development of pharmacological and chemical

research for application to traditional medicine in developing countries.

Journal of Ethnopharmacology 2(2), 173-181.

Fawcett, J.K., Scott, J.E., 1960. A rapid and precise method for the

determination of urea. Journal of Clinical Pathology 13, 156.

Felig, P., 1984. Protamine insulin - Hagedorn’s pioneering contribution to

drug delivery in the management of diabetes. Journal of the American

Medical Association 251, 393–396.

Ferri, G.L., Bloom, S.R., Polak, J.M., 1987. Morphologyof the islets of

Langerhans. In: Howard, J.M., Jordan, G.L., Reber, H.A., edition.

Surgical disease of the pancreas, Philadelphia.

Ferry, G., 1998. Dorothy Hodgkin: A life. Granta Books, London.

Finegood, D.T., Scaglia, L., Bonner-Weir, S., 1995. Dynamics of beta-cell

mass in the growing rat pancreas: estimation with a simple

mathematical model. Diabetes 44, 249–256.

Fiske, G.H., Subbarrow, Y., 1925. The colorimetric determination of

phosphorus. Journal of Biological Chemistry 66, 375–400.

Fiuza, S.M., Gomes, C., Teixeira, L.J., Giro da Cruz, M.T., Cordeiro,

M.N.D.S., Milhazes, N., Borges, F., Marques, M.P.M., 2004. Phenolic

acid derivatives with potential anticancer properties-a structure-activity

relationship study. Part 1: Methyl, propyl and octyl esters of caffeic and

gallic acids. Bioorganic & Medicinal Chemistry 12(13), 3581–3589.

Forney, R. M., Miyakosni, J., Day R.S., Paterson, M.C., 1988. Northern

blotting: Efficient RNA staining and transfer. Focus (Idaho) 10, 5-7.

Francis, G.A., Annicotte, J.S., Auwerx, J., 2003. PPAR agonists in

the treatment of atherosclerosis. Current Opinion in Pharmacology 3,

186–191.

Frode, T.S. , Medeiros, Y.S., 2008. Animal models to test drugs with

potential antidiabetic activity. Journal of Ethnopharmacology 115,

173–183.

Frojdo S., Cozzone, D., Vidal, H., Pirola, L., 2007. Resveratrol is a class IA

phosphoinositide 3–kinase inhibitor. Biochemical Journal 406, 511–518.

Frost, T., Kunt, T., Pfutzner, A., Beyer, J., Wahren, J., 1998. New aspects

on biological activity of C–peptide in IDDM patients. Experimental and

Clinical Endocrinology and Diabetes 106, 270–276.

Fukumoto, H., Kayano, T., Buse, J.B., Edwards, Y., Pilch, P.F., Bell,

G.I., Seino, S., 1989. Cloning and characterization of the major

insulin-responsive glucose transporter expressed in human skeletal

muscle and other insulin-responsive tissues. Journal of Biological

Chemistry 264, 7776–7779.

Gale, E.A.M., 2001. Lessons from the glitazones: a story of drug

development. Lancet 357, 1870–1875.

Gampe, R.T., Jr., Montana, V.G., Lambert, M.H., Miller, A.B., Bledsoe, R.K.,

Milburn, M.V., Kliewer, S.A., Willson, T.M., Xu, H.E., 2000. Asymmetry

in the PPARgamma/RXRalpha crystal structure reveals the molecular

basis of heterodimerization among nuclear receptors. Molecular Cell 5,

545–555.

Gancedo, J.M., Gancedo, C., 1971. Fructose 1, 6-biphosphatase,

phosphofructokinase and glucose 6-phosphate dehydrogenase from

fermenting yeast. Archives of Microbiology 76, 132–138.

Ganda, O.P., Rossi, A.A., Like, A.A., 1976. Studies on streptozotocin

diabetes. Diabetes 25, 595–603.

Gao, H., Huang, Y.N., Gao, B., Li, P., Inagaki, C., Kawabata, J.,

2008. Inhibitory effect on α-glucosidase by Adhatoda vasica Nees. Food

Chemistry 108, 965–972.

Garvey, W.T., Huecksteadt, T.P., Birnbaum, M.J., 1989. Pretranslational

suppression of an insulin-responsive glucose transporter in rats with

diabetes mellitus. Science 245, 60–63.

Gehlhaar, D.K., Verkhivker, G.M., Rejto, P.A., Sherman, C.J., Fogel, D.B.,

Fogel, L.J., Freer, S.T., 1995. Molecular recognition of the inhibitor

AG-1343 by HIV-1 protease: conformationally flexible docking by

evolutionary programming. Chemistry and Biology 2, 317–324.

Genet, S.,Raosaheb, K.K., Najma, Z.B., 1999. Effects of vanadate, insulin

and fenugreek (Trigonella foenum graecum) on creatine kinase level

in tissues of diabetic rat. Indian Journal of Experimental Biology 37,

200–202.

Gerich, J.E., 1985. Sulphonylureas in the treatment of diabetes mellitus.

Clinical Procedures 60, 439–443.

Ghosh, S., Suryawanshi, S.A., 2001. Effect of Vinca rosea extracts in

treatment of alloxan diabetes in male albino rats. Indian Journal of

Experimental Biology. 39, 748–759.

Giardino, I., Edelstein, D., Brownlee, M., 1996. BCL–2 expression or

antioxidants prevent hyperglycemia-induced formation of intracellular

advanced glycation endproducts in bovine endothelial cells. Journal of

Clinical Investigation 97(6), 1422–1428.

Gilde, A.J., Van Bilsen, M., 2003. Peroxisome proliferator–activated

receptors (PPARS): regulators of gene expression in heart and skeletal

muscle. Acta Physiologica Scandinavica 178, 425–434.

Giroix M.H., Portha, B., Kergoat, M., Bailbe, D., Picon, L., 1983.

Glucose insensitivity and amino-acid hypersensitivity of insulin release

in rats with non-insulin-dependent diabetes: a study with the perfused

pancreas. Diabetes 32, 445–451.

Giugliano, D., Ceriello, A., Paolisso, G., 1996. Oxidative stress and diabetic

vascular complications. Diabetes Care 19, 257–267.

Gohlke, H., Klebe, G., 2001. Statistical potentials and scoring functions

applied to protein-ligand binding. Current Opinion in Structural Biology

on Science 11, 231–235.

Golden, S., Wals, P.A., Okajima, F., Katz, J., 1979. Glycogen synthesis by

hepatocytes from diabetic rats. Biochemical Journal 182(3), 727–734.

Goldstein, D.E., Parker, K.M., England, J.D., 1982. Clinical application of

glycosylated hemoglobin measurements. Diabetes 31, 70–78.

Gomes, M.B., Lucchetti, M.R., Gonalves, M.F., Gazzolla, H., Dimetz, T.,

Matos H., 1997. Influence of first morning urine volume, fasting blood

glucose and glycosylated hemoglobin on first morning urinary albumin

concentration. Brazilian Journal of Medical and Biological Research 30,

191–196.

Goossens, G.H., 2008. The role of adipose tissue dysfunction in the

pathogenesis of obesity-related insulin resistance. Physiology and

Behavior 94(2), 206–218.

Goth, M.D., 1985. Medical Pharmacology, 9th edition, Mosby, C.V., St.

Louis.

Griesmacher, A., Kindhauser M., Andert S. E., SchreinerW., Toma C.,

Knoebl P., Pietschmann, P., Prager R., Schnack C., Schernthaner

G., Mueller, M.M., 1995. Enhanced serum levels of thiobarbituric

acid reactive substance in diabetes mellitus. The American Journal of

Medicine 98, 469–475.

Groop, L., Harno, K., Nikkila, E.A., Pelkonen, B., Tolppanen, E.M.,

1985. Transient effect of the combination of insulin and sulfonylurea

(Glibenclamide) on glycemic control in non-insulin dependent diabetics

poorly controlled with insulin alone. Acta Medica Scandinavica 17, 33–39.

Grover, J.K., Vats, V., 2001. Shifting Paradigm “from conventional to

alternate medicine.” An introduction on traditional Indian medicine. Asia

Pacific Biotechnology News 5 (1), 28–32.

Grover, J.K., Yadav, S.P. and Vats, V., 2002. Medicinal plants of India with

anti-diabetic potential. Journal of Ethnopharmacology 81, 81–100.

Grover, J.K., Yadav, S.P., Vats, V., 2003. Effect of feeding Murraya koeingii

and Brassica juncea diet on kidney functions and glucose levels in

streptozotocin diabetic mice. Journal of Ethnopharmacology 85, 1–5.

Gutman, A., 1986. Regulation of glycogen metabolism. In: Regulation of

Carbohydrate Metabolism. Vol II. R. Beitner, editor. CRC Press, Boca

Raton, FL. 33–52.

Gutteridge, J.M.C., 1995. Lipid peroxidation and antioxidant as biomarkers

of tissue damage. Clinical Chemistry 14, 1819–1828.

Ha, S., Andreani, R., Robbins, A., Muegge, I., 2000. Evaluation of

docking/scoring approaches: a comparative study based on MMP3

inhibitors, Comput. The Journal of Computer-Aided Molecular Design 14,

435–448.

Hagedorn, H., B. Jensen, N. Krarup, and I. Wodstrup. 1936. Portamine

Insulinate. Journal of the American Medical Association 106, 177–180.

Hamada, S., Kataoka, T., Woo, J.T., Yamada, A., Yoshida, T., Nishimura,

T., Otake, N., Nagai, K., 1997. Immunosuppressive effects of gallic

acid and chebulagic acid on CTL-mediated cytotoxicity. Biological and

Pharmaceutical Bulletin 20(9), 1017–1019.

Handelsman, D.J., Turtle, J.R., 1981. Clinical trial of an aldose reductase

inhibitor in diabetic neuropathy. Diabetes 30, 459–464.

Hansen, A., Johansson, B.L., Wahren, J., von Bibra, H., 2002. C-Peptide

exerts beneficial effects on myocardial blood flow and function in patients

with Type 1 Diabetes. Diabetes 51, 3077–3082.

Hara, Y., Honda, M., 1990. The inhibition of α-amylase by tea polyphenols.

Agricultural and Biological Chemistry 54, 1939–1945.

Helder, C., Oliveira, Maisa P. dos Santos , Rafael Grigulo, Layla L.

Limaa, Domingos T.O. Martins , Joaquim C.S. Limab, Luiz F. Stoppiglia

, Carbene F. Lopes , Nair H. Kawashita, 2008. Antidiabetic activity of

Vatairea macrocarpa extract in rats. Journal of Ethnopharmacology 115,

515–519.

Heller, B., Burkle, A., Radons, J., Fengler, E., Jalowy, A., Muller,

M., Burkart, V., Kolb, H., 1994. Analysis of oxygen radical toxicity

in pancreatic islets at the single cell level. Biological Chemistry

Hoppe-Seyler 375, 597–602.

Heller, S., Kozlovski, P., Kurtzhals, P., 2007. Insulin’s 85th anniversary –

An enduring medical miracle. Diabetes Research and Clinical Practice

78, 149–158.

Henke B.R., Blanchard S.G., Brackeen M.F., Brown K.K., Cobb J.E.,

Collins J.L., Harrington W.W. Jr, 1998. N-(2-Benzoylphenyl)-L-tyrosine

PPARgamma agonists. 1. Discovery of a novel series of potent

antihyperglycemic and antihyperlipidemic agents. Journal of Medicinal

Chemistry 41, 5020–5036.

Herman, L.S., Schersten, B., Bitzen, P.O., Kjellstorm, T., Lindgand, F.,

Melandes, A., 1994. Therapeutic comparison of metformin and sulphohyl

urea, alone and in various combinations. A double–bind controlled study.

Diabetes Care 17, 1109–1119.

Hers, H.G. , Van Schaftingen, E. 1982. Fructose 2,6-bisphosphate: Two

years after its discovery. Biochemistry Journal 206(1), 1–12.

Hers, H.G., Hue, L., 1983. Regulation of hepatic glycolysis and

gluconeogenesis. Annual Review of Biochemistry 52, 617—-53.

Hodgkinson A.D., Bartlett T., Oates P.J., Millward B.A., Demaine A.G.,

2003. The Response of Antioxidant Genes to Hyperglycemia Is Abnormal

in Patients With Type 1 Diabetes and Diabetic Nephropathy. Diabetes

52(3), 846–851.

Holloszy, J.O., Coyle, E.F., 1984. Adaptations of skeletal muscle to

endurance exercise and their metabolic consequences, Journal of Applied

Physiology 56, 831–839.

Hooft, R., 2003. Drug discovery and development for metabolic diseases.

Drug Discovery Today, 8, 1064–1066.

Hoogwerf, B.J., Bantle, J.P., Gaenslen, H.E., Greenberg, B.Z., Senske, B.J.,

Francis, R., Goetz, F.C., 1986. Infusion of synthetic human C-peptide does

not affect plasma glucose, serum insulin, or plasma glucagons in healthy

subjects. Metabolism 35, 122–125.

Horwitz, D.L., Kuzuya, H., Rubenstein, A.H., 1976. Circulating serum

C-peptide: a brief review of diagnostic implications. New England

Journal of Medicine 295, 207–209.

Houseknecht, K.L., Cole, B.M., Steele, P.J., 2002. Peroxisome Proliferator

activated receptor gamma (PPARg) and its ligands: a review. Domestic

Animal Endocrinology 22, 1–23.

Huang, S., Czech, M.P., 2007. The GLUT 4 Glucose Transporter. Cell

Metabolism 5(4), 237–252.

Huang, T.H., Peng, G., Kota, B.P., Li, G.Q., Yamahara, J., Roufogalis, B.D.,

Li, Y., 2005. Anti-diabetic action of Punica granatum flower extract:

activation of PPAR-gamma and identification of an active component.

Toxicology and Applied Pharmacology 207(2), 160–169.

Huang, T.H., Kota, B.P., Razmovski, V., Roufogalis, B.D., 2005a. Herbal

or natural medicines as modulators of peroxisome proliferator-activated

receptors and related nuclear receptors for therapy of metabolic

syndrome. Basic Clin Pharmacol Toxicol 96, 3–14.

Hubbard, S.R., Wei, L., Ellis, L., Hendrickson, W.A., 1994. Crystal structure

of the tyrosine kinase domain of the human insulin receptor. Nature

372(6508), 746–754.

Hwang, E.Y., Huh, J.W., Choi, M.M., Choi, S.Y., Hong, H.N., Cho, S.W.,

2008. Inhibitory effects of gallic acid and quercetin on UDP-glucose

dehydrogenase activity. FEBS Letters 582(27), 3793–3797.

Hye-Jeong Kim, Young-Chul Kim, 2010. Antidiabetic and renoprotective

effects of Corni Fructus extract in db/db mice. Molecular & Cellular

Toxicology 6, 135–142.

Ichinose, K., Kawasaki, E., Eguchi, K., 2007. Recent Advancement

of Understanding Pathogenesis of Type 1 Diabetes and Potential

Relevance to Diabetic Nephropathy. American Journal of Nephrology

27(6), 554–564.

Ido, Y., Vindigni, A., Chang, K., Stramm, L., Chance, R., Heath, W.F.,

DiMarchi, R.D., Di Cera, E., Williamson, J. R., 1997. Prevention of

Vascular and Neural Dysfunction in Diabetic Rats by C–Peptide, Science

277(5325), 563–566.

Ignacimuthu, S., Amalraj, T., 1998. Effect of leaf extract of Zizyphus jujuba

on diabetic rats. Indian Journal of Pharmacology 30, 107–108.

Imura, H., 1998. A novel antidiabetic drug, troglitazone: Reason for hope

and concern. New England Journal of Medicine 338(13), 908–909.

Iqbal, A., Zafar, M., Faiz, M., 1998. Screening of some Indian medicinal

plants for their antimicrobial properties. Journal Ethnopharmacol 62(2),

183–193.

Isao Kubo, Ken-ichi Fujita, Ken-ichi Nihei,. 2002. Anti–Salmonella Activity

of Alkyl Gallates. Journal of Agricultural and Food Chemistry 50(23),

6692–6696.

Ivorra, M.D., Paya,M., Villar, A., 1989. A review of natural products and

plants as potential antidiabetic drugs. Journal of Ethnopharmacology 27,

243–275.

Iwata, S., Nagata, N., Omae, A., Yamaguchi, S., Okada, Y., Shibata,

S., Okuyama, T., 1999. Inhibitory effect of chalcone derivatives on

recombinant human aldose reductase. Biological and Pharmaceutical

Bulletin 22(3), 323–325.

Jackson, R.L., Hess, R.L., England, J.D., 1979. Hemoglobin A1c values in

children with overt diabetes maintained in varying degrees of control.

Diabetes Care 2, 391–395.

Jadon, A., Bhadauria, M., Shukla, S., 2007. Protective effect of Terminalia

belerica Roxb. and gallic acid against carbon tetrachloride induced

damage in albino rats. Journal of Ethnopharmacology 109(2), 214–218.

Jafri, M.A., Aslam, M., Javed, K., Singh, S., 2000. Effect of

Punica granatum Lonn. (flowers) on blood glucose level in normal

and alloxan-induced diabetic rats. Journal of Ethnopharmacology 70,

309–314.

Jain S.K., 1999. Medicinal plants. National book trust, India, 178.

Jari Summanena, Pia Vuorelaa,, Jussi-Pekka Rauhaa, Pivi Tammelaa,

Krista Marjamkia, Michael Pasternackc, Kid Trnquistd, Heikki Vuorela.

2001. Effects of simple aromatic compounds and flavonoids on Ca2+

fluxes in rat pituitary GH4C1 cells. European Journal of Pharmacology.

414(2–3), 125–133.

Jasra, P.K., Talesara, C.L., 1986. Effects of alloxan diabetes on innervated

and denervated young rat muscles : A correlative histochemical,

biochemical and electrophoretic study. Indian Journal of Experimental

Biology 24, 163–168.

Jeloder, G., Mohsen, M., Shahram, S., 2007. Effect of walnut leaf,

coriander and pomegranate on blood glucose and histopathology of

pancreas of alloxan induced diabetic rats. African Journal of Traditional,

Complimentary and Alternative Medicines 4(3), 299–305.

Jennings, P.E., McLaren, M., Scott, N.A., Saniabadi, A.R., Belch, J.J.F.,

1991. The Relationship of Oxidative Stress to Thrombotic Tendency in

Type 1 Diabetic Patients with Retinopathy. Diabetic Medicine 8, 860–865.

Jerzy Gnojkowski, Violetta Krajka-Kuzniak, Wanda Baer-Dubowska

Monoclonal, 2001. Antibody-Directed Analysis of Benzo[a]pyrene

Metabolism in Rat Liver and Extrahepatic Tissues: Effect of Propyl and

Octyl Gallate. Nutrition and Cancer 39(1), 117–125.

Johansson, B.L., Sjoberg, Wahren, J., 1992. The influence of human

C-peptide on renal function and glucose utilization in type 1

(insulin-dependent) diabetic patients. Diabetologia 35, 121–128.

Johansson, B.L., Borg, K., Fernqvist–Forbes, E., Odergren, T., Remahl, S.,

Wahren, J., 1996. C-peptide improves autonomic nerve function in IDDM

patients. Diabetologia 39, 687–695.

Johansson, B.L., Borg, K., Fernqvist-Forbes, E., Kernell, A., Odergren, T.,

Wahren, J., 2000. Beneficial effects of C-peptide on incipient nephropathy

and neuropathy in patients with type 1 diabetes mellitus. Diabetic

Medicine 17(3), 181–189.

Jones, J.P., Dohm, L., 1997. Regulation of glucose transporter GLUT 4 and

hexokinase II gene transcription by insulin and epinephrine. American

Journal of Physiology 273, E682–E687.

Joost, H.G., Bell, G.I., Brinmaum, M.J., Charron, M.J., Chen, Y.T.,

Doege, H., James, D.E., Lodish, H.F., Moley, J.F., Mueekler, M.,

Rogers, S., Schurman, A., Seino, S., Thorens, B., 2002. Nomenclature

of the GLUT/SLC2A family of sugar polyol transport facilities. American

Journal of Physiology - Endocrinology and Metabolism 282, 974–976.

Kahn, B.B., Rossetti, L., Lodish, H.F., Charron, M.J., 1991. Decreased

in vivo glucose uptake but normal expression of GLUT 1 and GLUT 4

in skeletal muscle of diabetic rats. Journal of Clinical Investigation 87,

2197–2206.

Kakkar, P., Das, B., Viswanathan, P.N., 1984. A modified

spectrophotometric assay of superoxide dismutase. Indian Journal

of Biochemistry and Biophysics 21, 130–132.

Kaleem, M., Medha, P., Ahmed, Q.U., Asif, M., Bano, B., 2008. Beneficial

effects of Annona squamosa extract in streptozotocin-induced diabetic

rats. Singapore Medical Journal 49(10), 800–804.

Kamalakkannan, N., Prince, P.S., 2005. The effect of Aegle marmelos fruit

extract in streptozotocin diabetes: a histopathological study. Journal of

Herbal Pharmacotherapy 5, 87–96.

Kameswara Rao, B., Renuka Sudarshan, P., Raja Sekar, M.D., Nagaraju,

N., and Appa Rao, C.H., 2003. Antidiabetic activity of Terminalia pallida

fruit in alloxan induced diabetic rats. Journal of Ethnopharmacology 85,

169–172.

Kamtchouing, P., Kahpui, S.M., Djomeni Dzeufiet, P.–D., Tdong,

L., Asongalem, E.A., Dimo, T., 2006. Anti-diabetic activity of

methanol/methylene chloride stem bark extracts of Terminalia superba

and Canarium schweinfurthii on streptozotocin-induced diabetic rats.

Journal of Ethnopharmacology 104(3), 306–309.

Kapoor, L.D., 1990. Handbook of Ayurvedic Medicinal Plants. CRC Press,

Boca Raton, 321.

Karalee, J.J., Anderson, R.A., Graves, D.A., 2001. Hydroxychalcone derived

from cinnamon functions as a mimetic for insulin in 3T3-L1 adipocytes.

Journal of the American College of Nutrition 20, 327–336.

Karunanayake, E.H., Welihinda, J., Sirimanne, S.R., Sinnadorai, G., 1984.

Oral hypoglycaemic activity of some medicinal plants of Sri Lanka.

Journal of Ethnopharmacology 11, 223–231.

Kasuga, M., Karlsson, F.A., Kahn, C.R., 1982. Insulin stimulates the

phosphorylation of the 95,000-Dalton subunit of its own receptor. Science

215, 185–187.

Katoh, M., Ohmachi, Y., Kurosawa, Y., Yoneda, H., Tanaka, N., Narita,

H., 2000. Effects of imidapril and captopril on streptozotocin-induced

diabetic nephropathy in mice. European Journal of Pharmacology 398(3),

381–387.

Katsumata, K., Katsumata, K., Jr., Katsumata, Y., 1992. Protective

effect of diltiazem hydrochloride on the occurrence of alloxan-

or streptozotocin-induced diabetes in rats. Hormone and Metabolic

Research 24, 508–510.

Kaur S., Arora S., Kaur K., Kumar S., 2002. The in vitro antimutagenic

activity of Triphala, an Indian herbal drug, Food and Chemical Toxicology

40, 527–534.

Kavalali, G., Tuncel, H., Gksel, S., Hatemi, H.H., 2003. Hypoglycemic

activity of Urtica pilulifera in streptozotocin-diabetic rats. Journal of

Ethnopharmacology 84(2-3), 241–245.

Kedziora-Kornatowska, K., Szewczyk-Golec, K., Kozakiewicz, M., Pawluk,

H., Czuczejko, J., Kornatowski, T., Bartosz, G., Kedziora, J., 2009.

Melatonin improves oxidative stress parameters measured in the blood

of elderly type 2 diabetic patients. Journal of Pineal Research 46(3),

333–337.

Kennedy, A.L., Mehl, T.D., Merimee, T.J., 1981. Non-enzymatically

glycoslylated serum protein in diabetes mellitus. An index of short-term

glycaemia. Diabetologia 21, 94–98.

Khanna, A.K., Rameshchander, Kapoor, N.L., 1996. Terminalia arjuna

an ayurvedic cardiotonic regulates lipid metabolism. Phytotherapy 10,

663–665.

Kim J.S., Kwon C.S., Son K.H., 2000. Inhibition of alpha-glucosidase

and amylase by luteolin, a flavonoid. Bioscience, Biotechnology, and

Biochemistry 64, 2458–2461.

Kim, M.J., Ryu, G.R., Chung, J.S., Sim, S.S., Min, D.S., Rhie, D.J.,

Yoon, S.H., Hahn, S.J., Kim, M.S., Jo, Y.H., 2003. Protective effects of

epicatechin against the toxic effects of streptozotocin on rat pancreatic

islets: in vivo and in vitro., Pancreas 26, 292–299.

Kim, H.K., Kim, M.J., Cho, H.Y., Kim, E.K., Shin, D.H., 2006. Antioxidative

and anti-diabetic effects of amaranth (Amaranthus esculantus) in

streptozotocin induced diabetic rats. Cell Biochemistry and Function 24,

195–199.

Kim, S.-H., Jun, C.-D., Suk, K., Choi, B.-J., Lim, H., Park, S., Lee,

S. H., Shin, H.-Y., Kim, D.-K., Shin, T.-Y., 2006. Gallic acid inhibits

histamine release and pro–inflammatory cytokine production in mast

cells. Toxicological sciences 91(1), 123–131.

Kind, P.R.N., King, E.J., 1954. Estimation of plasma phosphatases by

determination of hydrolyzed phenol with amino-antipyrine. Journal of

Clinical Pathology 7, 330–322.

Kirtikar, K. R., Basu, B. D., 1933. Terminalia Linn, 2., Indian Medicinal

Plants, 2nd ed., Lalit Mohan Basu, Allahabad, India, 1014–1033.

Kitada, M., Koya, D., Sugimoto, T., Isono, M., Araki, S., Kashiwagi, A.,

Haneda, M., 2003. Translocation of glomerular p47phox and p67phox by

protein kinase C-β activation is required for oxidative stress in diabetic

nephropathy. Diabetes 52(10), 2603–2614.

Klip, A., Ramlal, T., Bilan, P.J., Cartee, G.D., Gulve, E.A., Holloszy,

J.O., 1990. Recruitment of GLUT 4 glucose transporters by insulin

in diabetic rat skeletal muscle. Biochemical and Biophysical Research

Communication 172, 728–736.

Kobayashi Y, Suzuki M, Hideo S, Arai S, Yukihiko H, Suzuki K,

Miyamoto Y, Shimizu, M., 2000. Green tea polyphenols inhibit the

sodium–dependent glucose transporter of intestinal epithelial cells by a

competitive mechanism. Journal of Agricultural and Food Chemistry 48,

5618–5623.

Koenig, R. J., Peterson, C. M., Jones,. R. L., Saudek, C., Lehrman, M.,.

Cerami, A. 1976. Correlation of glucose regulation and hemoglobin A1c in

diabetes mellitus. New England Journal of Medicine 295, 417–420.

Koren J. A., Teuber, S.S., Gobeille, A., Cremin, P., Waterhouse, A.L.,

Steinberg, F.M., 2001. Walnut Polyphenolics Inhibit In Vitro Human

Plasma and LDL Oxidation. Journal of Nutrition 131, 2837–2842.

Koya, D., King, G.L., 1998. Protein kinase C activation and the development

of diabetic complications. Diabetes 47, 859–866.

Kratz, J.M., Andrighetti-Frhner, C.R., Leal, P.C., Nunes, R.J., Yunes, R.A.,

Trybala, E., Bergstrm, T., Barardi, C.R., Simes, C.M., 2008. Evaluation

of anti-HSV-2 activity of gallic acid and pentyl gallate. Biological and

Pharmaceutical Bulletin 31(5), 903–907.

Kreander, K., Vuorela, P., Tammela, A., 2005. A rapid screening method

for detecting active compounds against erythromycin-resistant bacterial

strains of Finnish origin. Folia Microbiologica 50(6), 487–493.

Krische, D., 2000. The glitazones: proceed with caution. The Western

Journal of Medicine 173, 54–57.

Kris-Etherton, P.M., Hecker, K.D., Bonanome, A., Coval, S.M., Binkoski,

A.E., Hilpert, K.F., Griel, A.E., Etherton, T.D., 2002. Bioactive compounds

in foods: their role in the prevention of cardiovascular disease and cancer.

The American Journal of Medicine 113, 71–88.

Kristiansen, S., Nielsen, J.N., Bourgoin, S., Klip, A., Franco, M., Richter,

E.A., 2001. GLUT-4 translocation in skeletal muscle studied with a

cell-free assay: involvement of phospholipase D. American Journal of

Physiology - Endocrinology and Metabolism 281, E608E618.

Kroncke, K.D., Fehsel, K., Sommer, A., Rodrigue, M.L., Kolb-Bachofen,

V.,1995. Nitric oxide generation during cellular metabolization of the

diabetogenic N-methyl-N-nitroso-urea streptozotocin contributes to islet

cell DNA damage. Biological Chemistry Hoppe-Seyler 376, 179–185.

Kumar, P.J., Clark, M., 2002. Diabetes mellitus and other disorders of

metabolism.In: Clinical Medicine, Saunders(London), 1069–1121.

Kumar, G, Murugesan, A.G., 2007. Influence of Helicteres isora bark

extracts on plasma and tissue glycoprotein components in streptozotocin

diabetic rats. Journal of Clinical and Diagnostic Researc 4, 330–338.

Kumar, G., Sharmila, B.G.,Vanita, P.P., Sundararajan, M., Rajsekara, P.M.,

2004. Hepatoprotective activity of Trianthema portuacastrum L. against

paracetamol and thioacetamide intoxication in albino rats. Journal of

Ethnopharmacology 92, 37–40.

Lacy, P.E., Davie, J.M., 1984. Transplantation of pancreatic islets. Annual

Review of Immunology 2, 183–198.

Laemmli, U.K., 1970. Cleavage of structural protein during the assembly of

the head bacteriophage T4. Nature 227, 680685.

Laplante, M., Sell, H., MacNaul, K.L., Richard, D., Berger, J.P., Deshaies,

Y., 2003. PPAR-gamma activation mediates adipose depot-specific effects

on gene expression and lipoprotein lipase activity: Mechanisms for

modulation of postprandial lipemia and differential adipose accretion.

Diabetes 52, 291–299.

Larner, J., 1985. Insulin and oral hypoglycemic drugs. In: Gilman, A.,

Goodman, L.S., Rall, T.W. and Murad, F., edition. The Pharmacological

Basis of Therapeutics, 7th edition, Macmillan, New York.

Larsen,T.M., Toubro,S., Astrup,A., 2003. PPAR gamma agonists in the

treatment of type II diabetes: is increased fatness commensurate with

long term efficacy. International Journal of Obesity Relatated Metabolic

Disorder 27, 147–161.

Larson, R.A., 1988. The antioxidants of higher plants. Phytochemistry 27,

969–978.

Latha R.C.R., Daisy P., 2010. Influence of Terminalia bellerica Roxb.

fruit extracts on biochemical parameters in streptozotocin diabetic rats,

International Journal of Pharmacology 6, 89–96.

Latha R.C.R., Daisy P., 2008. Effect of Costus pictus D. Don in

streptozotocin induced diabetic rats. Biochemical and Cellular Archives,

8(2), 173-178.

Laychock, S.G., 1990. Glucose metabolism, second messengers and insulin

secretion. Life Science 47, 2307–2316.

Leahy, J.L., 2005. Pathogenesis of Type 2 Diabetes Mellitus. Archives of

Medical Research 36(3), 197–209.

Leahy, J.L., Halban, P.A., Weir, G.C., 1991. Relative hypersecretion of

proinsulin in rat model of NIDDM. Diabetes. 40(8), 985–989.

Leahy, J.L., Weir, G.C.,1988. Evolution of abnormal insulin secretory

responses during 48-h in vivo hyperglycemia. Diabetes 37(2), 217–222.

Lebovitz, H.E., Pasmantier, R., 1990. Combination insulin–sulphonylurea

therapy. Diabetes Care 13, 667–675.

Lee, B., Jonas, J.C., Weir G.C., Laychock, S.G., 1999. Glucose regulates

expression of inositol 1, 4, 5- trisphosphate receptor isoforms in isolated

rat pancreatic islets. Endocrinology 140, 2173–2182.

Lee, H.S., Won, N.H., Kim, K.H., Lee, H., Jun, W., Lee, K.W., 2005.

Antioxidant effects of aqueous extract of Terminalia chebula in vivo and

in vitro. Biological and Pharmaceutical Bulletin 28(9), 1639–1644.

Lee, J.S., 2006. Effects of soy protein and genistein on blood glucose,

antioxidant enzyme activities, and lipid profile in streptozotocin-induced

diabetic rats. Life Sciences 79(16), 1578–1584.

Lee, H.S., Jung, S.H., Yun, B.S., Lee, K.W., 2007. Isolation of chebulic acid

from Terminalia chebula Retz. and its antioxidant effect in isolated rat

hepatocytes. Archives of Toxicology 81(3), 211–218.

Lehmann J.M., Moore L.B., Smith-Oliver T.A., Wilkison W.O., Willson T.M.,

Kliewer S.A., 1995. An antidiabetic thiazolidinedione is a high affinity

ligand for peroxisome proliferator-activated receptor gamma (PPAR-γ).

Journal of Biological Chemistry 270, 12953–12956.

Leibowitz, J.O., 1972. The concept of diabetes in historical perspective.

Israel Journal Medicine and Science 8, 469–475.

Leloir, L.F., Goldemberg, S.H., 1960. Synthesis of Glycogen from Uridine

Diphosphate Glucose in Liver. Journal of Biological Chemistry 235(4),

919.

Leloir, L.F., Olavarra, J.M., Goldemberg, S.H., Carminatti, H., 1959.

Biosynthesis of glycogen from uridine diphosphate glucose. Archives of

Biochemistry and Biophysic 81, 508–520.

Leng, S.H., Lu, F.E., Xu, L.J., 2004. Therapeutic effects of berberine in

impaired glucose tolerance rats and its influence on insulin secretion.

Acta Pharmacologica Sinica 25(4), 496–502.

Lenzen, S., Tiedge, M., Jorns, A., Munday, R., 1996. Alloxan derivatives as

a tool for the elucidation of the mechanism of the diabetogenic action of

alloxan. In: Shafrir, E. (Ed.), Lessons from Animal Diabetes. Birkhauser,

Boston, pp. 113–122.

Lenzen, S., Drinkgren, J. and Tiedg, M., 1996a. Low antioxidant enzyme

gene expression in pancreatic islets compared with various other mouse

tissues. Free Radical Biology and Medicine 20, 463–466.

Li, W., Dai, R.J., Yu, Y.H., Li, L., Wu, C.M., Luan, W.W., Meng, W.W., Zhang,

X.S., Deng, Y.L., 2007. Antihyperglycemic Effect of Cephalotaxus sinensis

Leaves and GLUT 4 Translocation Facilitating Activity of Its Flavonoid

Constituents. Biological and Pharmaceutical Bulletin 30(6), 1123–1129.

Li, Y., Kim, J., Li, J., Liu, F., Liu, X., Himmeldirk, K., Ren,

Y., Wagner, T.E., Chen, X., 2005. Natural anti–diabetic compound

1,2,3,4,6-penta-O-galloyl-D-glucopyranose binds to insulin receptor

and activates insulin-mediated glucose transport signaling pathway.

Biochemical and Biophysical Research Communications 336(2), 430–437.

Lim, S.S., Jung, S.H., Ji, J., Shin, K.H., Keum, S.R., 2001. Synthesis of

flavonoids and their effects on aldose reductase and sorbitol accumulation

in streptozotocin-induced diabetic rat tissues. Journal of Pharmacy and

Pharmacology 53(5), 653–668.

Lin, J., Wu, H., Tarr, P.T., Zhang, C.Y., Wu, Z., Boss, O., Michael, L.F.,

Puigserver, P., Isotani, E., Olson, E.N., Lowell, B.B., Bassel-Duby, R.,

Spiegelman, B.M., 2002. Transcriptional co-activator PGC-1 alpha drives

the formation of slow-twitch muscle fibres. Nature 418, 797–801.

Liu, Y., Wan, Q., Gao, L., Zhao, J., 2006. High-fat diet feeding impairs both

the expression and activity of AMPKa in rat skeletal muscle. Biochemical

and Biophysical Research Communications 339, 701707.

Liu, I.M., Tzeng, T.F., Liou, S.S., Lan, T.W., 2007. Myricetin, a

naturally occurring flavonol, ameliorates insulin resistance induced by

a high-fructose diet in rats. Life Sciences 81(21–22), 1479–1488.

Liu, K.C., Huang, A.C., Wu, P.P., Lin, H.Y., Chueh, F.S., Yang, J.S., Lu,

C.C., Chiang, J.H., Meng, M., Chung, J.G., 2011. Gallic acid suppresses

the migration and invasion of PC-3 human prostate cancer cells via

inhibition of matrix metalloproteinase-2 and -9 signaling pathways.

Oncology Reports 26(1), 177-184.

Lollinger, J., 1981. Free Radicals and Food Additives. Ed. by Taylor and

Francis, London, 121.

Lo Scalzo, R., 2010. Measurement of free radical scavenging activity

of gallic acid and unusual antioxidants as sugars and hydroxyacids.

Electronic Journal of Environmental, Agricultural and Food Chemistry

9(8), 1360–1371.

Lou, M., Garrett, T., McKern, N., Hoyne, P., Epa, V., Bentley, J., Lovrecz,

G., Cosgrove, L., Frenkel, M., Ward, C., 2006. The first three domains of

the insulin receptor differ structurally from the insulin-like growth factor

1 receptor in the regions governing ligand specificity. Proceedings of the

National Academy of Sciences of the United States 103, 12429–12434.

Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R., 1951. Protein

Measurement with the Folin Phenol reagent. Journal of Biological

Chemistry 193, 265–275.

Lua, J.J., Weib, Y., Yuan, Q.P., 2007. Preparative separation of gallic

acid from Chinese traditional medicine by high-speed counter-current

chromatography and followed by preparative liquid chromatography,

Separation and Purification Technology 55, 40-43.

Luna, L.G., 1968. Manual of histology, Third edition, New York Mc Graw

Hill.

Luo, J.Z., Luo, L., 2006. American ginseng stimulates insulin production

and prevents apoptosis through regulation of uncoupling protein-2 in

cultured beta cells. Evidence-based Complementary and Alternative

Medicine 3, 365–372.

Lyons, T. J., 1991. Oxidized Low Density Lipoproteins: a Role in

the Pathogenesis of Atherosclerosis in Diabetes. Diabetic Medicine 8,

411–419.

Maddux, B.A., See,W., Lawrence Jr., J.C., Goldfine, A.L., Goldfine, I.D.,

Evans, J.L., 2001. Protection against oxidative stress-induced insulin

resistance in rat L6 muscle cells by micromolar concentrations of

alpha-lipoic acid. Diabetes 50, 404–410.

Manach, C., Scalbert, A., Morand, C., Rmsy, C., Jimnez, L., 2004.

Polyphenols:food sources and bioavailability. American Journal of

Clinical Nutrition 79, 727–747.

Manning, B.D., Cantley, L.C., 2007. AKT/PKB Signaling: Navigating

Downstream. Cell 129(7), 1261–1274.

Manoharan, S., Silvan, S., Vasudevan, K., Balakrishnan, S., 2007.

Antihyperglycemic and antilipidperoxidative effects of Piper longum

(Linn.) dried fruits in alloxan induced diabetic rats. International Journal

of Biological Sciences 6, 161–168.

Manoharan, S., Anish Kumar, R., Linsa Mary, A., Singh, R.B.,

Balakrishnan1, S., Silvan, S., 2009. Effects of Punica granatum

Flowers on Carbohydrate Metabolizing Enzymes, Lipid Peroxidation and

Antioxidants Status in Streptozotocin Induced Diabetic Rats. The Open

Nutraceuticals Journal 2, 113–117.

Maritim, A.C., Sanders, R.A., Watkins, J.B., 2003. Diabetes, oxidative

stress and antioxidants. A Review. Journal of Biochemical and Molecular

Toxicology 17, 24–38.

Marles,R.J., Farnsworth, N.R., 1995. Antidiabetic plants and their active

constituents. Phytomedicine 2, 137-189.

Marston, A., Maillard, M., Hostettmann, K., 1997. GIT Laboratory Journal

No. 1, 36–39.

Martineau, L.C., Couture, A., Spoor, D., Benhaddou–Andaloussi, A., Harris,

C., Meddah, B., Leduc, C., Burt, A., Vuong, T., Mai Le, P., Prentki,

M., Bennett, S.A., Arnason, J.T., Haddad, P.S., 2006. Anti-diabetic

properties of the Canadian lowbush blueberry Vaccinium angustifolium

Ait. Phytomedicine 13, 612–623.

Maruthappan, V., Sakthi Shree, K., 2010. Hypolipidemic activity of

Haritaki (Terminalia chebula) in atherogenic diet induced hyperlipidemic

rats. Journal of Advanced Pharmaceutical Technology & Research 1(2),

229–235.

Masiello, P., 2006. Animal models of type-2 diabetes with reduced

pancreatic β-cell mass. The International Journal of Biochemistry and

Cell Biology 38, 873–893.

Mathur, R., Sharma, A., Dixit, V.P., Varma, M., 1996. Hypolipidaemic effect

of fruit juice of Emblica officinalis in cholesterol fed rabbits. Journal of

Ethnopharmacology 50(2), 61–68.

Matsumoto, N., Ishigaki, F., Ishigaki, A., Iwashina, H., Hara, Y.,

1993. Reduction of blood glucose levels by tea catechin. Bioscience,

Biotechnology, and Biochemistry 57, 525–527.

Mauer, S. M., Steffes, M.W., Brown, D. M., 1981. The kidney in diabetes,

The American Journal of Medicine 70, 63–66.

Maurya, D.K., Nandakumar, N., Devasagayam, T.P., 2011. Anticancer

property of gallic acid in A549, a human lung adenocarcinoma cell line,

and possible mechanisms. Journal of Clinical Biochemistry and Nutrition

48(1), 85–90.

Mayes, P.A., 2003. Gluconeogenesis and control of the blood glucose. In

Harper’s Biochemistry. 25th edition, New York: McGraw-Hill, 208–218.

Mayfield, 1998. Diagnosis and classification of diabetes mellitus: New

criteria. American Family Physician 58, 1355-1362.

Mazunder, U.K., Gupta, M., Rajeshwar, Y., 2005. Antihyperglycemic effect

and antioxidant potential of Phyllanthus niruri (Euphorbiaceae) in

streptozotocin induced diabetic rats. Euro Bull Drug Res. 13, 19.

McKern, N., Lawrence, M., Streltsov, V., Lou, M., Adams, T., Lovrecz, G.,

Elleman, T., Richards, K., Bentley, J., Pilling, P., Hoyne, P., Cartledge, K.,

Pham, T., Lewis, J., Sankovich, S., Stoichevska, V., Silva, E., Robinson, C.,

Frenkel, M., Sparrow, L., Fernley, R., Epa, V., Ward, C., 2006. Structure

of the insulin receptor ectodomain reveals a folded-over conformation.

Nature 443, 218–221.

Meena, A.K., Yadav, A., Singh, U., Singh, B., Sandeep and Rao,

M.M.K., 2010. Evaluation of Physicochemical Parameters on the Fruit

of Terminalia Bellerica Roxb. International Journal of Pharmacy and

Pharmaceutical Sciences 2, 97–99.

Meistes, A., Anderson, M.E., 1983. Glutathione. Annual Review of

Biochemistry 52, 711–760.

Meyer, C., Stumvoll, M., Nadkarni, V., Dostou, J., Mitrakou, A., Gerich, J.,

1998. Abnormal renal and hepatic glucose metabolism in type 2 diabetes

mellitus. Journal of Clinical Investigation 102(3), 619–624.

Mitra, S.K., Gopumadhavan, S., Muralidhar, T.S., Seshadri, S.J., 1996.

Effect of D-400, a herbomineral formulation on liver glycogen content

and microscopic structure of pancreas and liver in streptozotocin induced

diabetes in rats. Indian Journal of Experimental Biology 34(10), 964–967.

Mlinar, B., Marc, J., Janez, A., Pfeifer, M., 2007. Molecular mechanisms

of insulin resistance and associated diseases. Clinica Chimica Acta

375(1–2), 20–35.

Moller, D. E., Greene, D. A., 2001. Peroxisome proliferator-activated

receptor (PPAR) agonists for diabetes. Advances in Protein Chemistry

56, 181–212.

Moreno, D.A., Ilic, N., Poulev, A., Brasaemle, D.L., Fried, S.K., Raskin, I.,

2003. Inhibitory effects of grape seed extract on lipases., Nutrition 19,

876–879.

Morgan, H. E., Parmeggiani, A. 1964. Regulation of glycogenolysis

in muscle. III. Control of muscle phosphorylase activity. Journal of

Biological Chemistry 239, 2440–2445.

Moron, M.A., De Pierre, J.W., Manner Vick, B., 1979. Levels of glutathione,

glutathione reductase and glutathione–S transferase activities in rat

liver. Biochimica et Biophysica Acta 582, 67–68.

Muegge, I., Martin, Y.C., A general and fast scoring function for

protein-ligand interactions: A simplified potential approach. Journal of

Medicinal Chemistry 42, 791–804.

Murase, Y., Imagawa, A., Hanafusa, T., Iwahashi, H., Uchigata, Y.,

Kanatsuka, A., Kawasaki, E., Kobayashi, T., Shimada, A., Shimizu,

I., Maruyama, T., Makino, H., 2007. Fulminant type 1 diabetes as a

high risk group for diabetic microangiopathya nationwide 5-year-study

in Japan. Diabetologia 50(3), 531–537.

Murray, R.K., Granner, D.K., Mayes, P.A., Rodwell, V.W. 2000. Proteins:

Myoglobin and Hemoglobin. Harpers Biochemistry, 24th edition, Prentice

Hall International, Eaglewood Cliffs, New Jersey.

Mutalik, S., Chetana, M., Sulochana, B., Devi, P.U., Udupa, N., 2005. Effect

of Dianex, a herbal formulation on experimentally induced diabetes

mellitus. Phytotherapy Research 19(5), 409–415.

Mythili, M.D., Vyas, R., Akila, G., Gunasekaran, S., 2004. Effect of

streptozotocin on the ultrastructure of rat pancreatic islets. Microscopy

Research and Technique 63, 274–281.

Nadkarni, A. K., 1954. Dr. K M. Nadkarni’s Indian Materia Medica. Vol. 1,

3rd Ed. Popular Book Depot, Bombay, India, 1202.

Nagappa, A.N., Thakurdesai, P.A., Rao, V.N., Singh, J., 2003.

Antidiabetic activity of Terminalia catappa Linn fruits. Journal of

Ethnopharmacology 88, 45–50.

Naik, G.H., Priyadarsini, K.I., Naik, D.B., Gangabhagirathi, R., Mohan, H.,

2004. Studies on the aqueous extract of Terminalia chebula as a potent

antioxidant and a probable radioprotector. Phytomedicine 11(6), 530–538.

Naik, G.H., Priyadarsini, K.I., Bhagirath, R.G., Mishra, B., Mishra, K.P.,

Banavalikar, M.M., Mohan, H., 2005. In vitro antioxidant studies and

free radical reactions of triphala, an ayurvedic formulation and its

constituents. Phytotherapy Research 19(7), 582–586.

Nakai, S., Shinzato, T., Nagura, Y., Masakane, I., Kitaoka, T., Shinoda,

T., Yamazaki, C., Sakai, R., Morita, O., Iseki, K., 2005. An overview of

regular dialysis treatment in Japan as of 31 December 2003. Therapeutic

Apheresis and Dialysis 9, 431–458.

Nan, J.X., Park, E.J., Nam, J.B., Zhao, Y.Z., Cai, X.F., Kim, Y.H., Sohn, D.H.,

Lee, J.J., 2004. Effect of Acanthopanax koreanum Nakai. (Araliaceae)

on d -galactosamine and lipopolysaccharide induced fulminant hepatitis.

Journal of Ethnopharmacology 92, 71–77.

Nandy, A.K., Podder, G., Sahu, N.P., Mahato, S.B., 1989. Triterpenoids

and their glucosides from Terminalia bellerica. Phytochemistry 28,

2769–2772.

Navarro, C.M., Montilla, P.M., Martin, A., Jimenez, J., Utrilla, P.M., 1993.

Free radicals scavenger and anti hepatotoxic activity of Rosmarinus.

Plant Medicine 59, 312–314.

Nichans, W.G., Samuelson, B., 1968. Formation of malondialdehyde

from phospholipid arachidonate during microsomal lipid peroxidation.

European Journal of Biochemistry 6(1), 126–130.

Nishikawa, T., Edelstein, D., Du, X.L., Yamagishi, S., Matsumura,

T., Kaneda, Y., Yorek, M.A., Beebe, D., Oates, P.J., Hammes, H.P.,

Giardino, I., Brownlee, M., 2000. Normalizing mitrochondrial superoxide

production blocks three pathways of hyperglycaemic damage. Nature

404, 787–790.

Nolte, R.T., Wisely, G.B., Westin, S., Cobb, J.E., Lambert, M.H.,

Kurokawa, R., Rosenfeld, M.G., Willson, T.M., Glass, C.K., Milburn,

M.V., 1998. Ligand binding and co-activator assembly of the peroxisome

proliferator-activated receptor-gamma. Nature 395, 137–143.

Noor, A., Gunasekeran, S., Manicckam, A.S., Vijayalakshmi, M.A.,

2008. Antidiabetic activity of Aloe vera and histology of organs in

streptozotocin-induced diabetic rats. Current Science 94(8), 1070–1076.

Noriko Yamabe, Takako Yokozawa, Takeshi Oya, Mujo Kim, 2006.

Therapeutic Potential of (–)-Epigallocatechin 3-O-Gallate on Renal

Damage in Diabetic Nephropathy Model Rats. Journal of Pharmacology

and Experimental Therapeutics 319, 228–236.

Nukatsuka, M., Yoshimura, Y., Nishida, M., Kawada, J., 1990. Importance

of the concentration of ATP in rat pancreatic beta cells in the mechanism

of streptozotocin-induced cytotoxicity. Journal of Endocrinology 127,

161–165.

Ohaeri, O.C., 2001. Effect of garlic oil on the levels of various enzyme

in the serum and tissue of streptozotocin diabetic rats. Bioscience and

Reproduction 21, 19–24.

Ohlstein, E.H., Ruffolo Jr., R.R., Ellroff, J.D., 2000. Drug discovery in the

next millennium. Annual Review of Pharmacology and Toxicology 40,

177–191.

Olefsky, J.M., 1999. Insulin-stimulated glucose transport minireview series.

Journal of Biological Chemistry 274, 1863.

Onozato, M.L., Tojo, A., Goto, A., Fujita, T., Wilcox, C.S., 2002. Oxidative

stress and nitric oxide synthase in rat diabetic nephropathy: effects of

ACEI and ARB. Kidney International 61, 186–194.

Orhan, N., Aslan, M., Hosbas, S., Deliorman, O.D., 2009. Antidiabetic

Effect and Antioxidant Potential of Rosa canina Fruits. Pharmacognosy

Magazine 5, 309–315.

Padmashree, Padmavathi P Prabhu, Sushanth Pandey., 2010. Anti diabetic

activity of methanol/methylene chloride extract of Terminalia superba

leaves on streptozotocin induced diabetes in rats. International Journal

of PharmTech Research 2(4), 2415–2419.

Paivi Tammela, Pia Vuorela, 2004. Miniaturisation and validation of a

cell-based assay for screening of Ca2+ channel modulators. Journal of

Biochemical and Biophysical Methods 59(3), 229–239.

Pavana, P., Sethupathy, S., Manoharan, S., 2007. Antihyperglycemic and

antilipidperoxidative effects of Tephrosia purpurea seed extract in STZ

induced diabetic rats. Indian Journal of Clinical Biochemistry. 22, 77–83.

Pessin, J. E., Thurmond, D. C., Elmendorf, J. S., Coker, K. J. and Okada, S.

1999. Molecular basis of insulin stimulated GLUT 4 vesicle trafficking.

Journal of Biological Chemistry 274, 2593–2596.

Peter A. Mayes, Kathleen M. Botham, 2000. Cholesterol synthesis,

transport and excretion. In: Harpers Biochemistry, 24th edition, Prentice

Hall International, Eaglewood Cliffs, New Jersey.

Picard F., Auwerx, J., 2002. PPAR-γ and glucose homeostasis. Annual

Review of Nutrition 22, 167–197.

Pilkis, S . J . , EI-Maghrabi, M. R . , Claus, T . H . 1 988. Hormonal

regulation of hepatic gluconeogenesis and glycolysis. Annual Review of

Biochemistry 57:755–83.

Pilkis , S. J . , EI-Maghrabi, M. R . , Claus, T . H . 1990. Role of fructose

2,6-bisphosphatate in the regulation of hepatic gluconeogenesis: From

metabolites to molecular genetics. Diabetes Care 13, 582–599.

Pinent, M., Blay, M., Blade, M.C., Salvado, M.J., Arola, L.,

Ardevol, A., 2004. Grape Seed-Derived Procyanidins Have an

Antihyperglycemic Effect in Streptozotocin-Induced Diabetic Rats and

Insulinomimetic Activity in Insulin-Sensitive Cell Lines. Endocrinology

145(11), 4985–4990.

Pirola, L., Johnston, A.M., Obberghen, E., 2004. Modulation of insulin

action. Diabetologia 47(2), 170–184.

Piyachaturawat, P., Poprasit, J., Glinsukon, T., Warichanon, C., 1988.

Gastric mucosal lesions in Streptozotocin diabetic rats. Cell Biology

International Reports 12(1), 53–63.

Piyachaturawat, P., Poprasit, J., Glinsukon, T., 1990. Gastric mucosal

secretions and lesions by different doses of Streptozotocin in rats.

Toxicology Letters 55, 21–29.

Plummer, T.D., 1987. An introduction to practical Biochemistry. Tata Mc

Graw Hill Company, UK, Whithington, 1984.

Pogano, G., S. Marena, L. Corgiat-Mansin, F. Cravero, C. Giorda and M.

Bozza, 1995. Comparison of miglitol and glibenclamide in diet-treated

type 2 diabetic patients. Diabetes and Metabolism 21, 162–167.

Poitout, V., Olson, L.K., Robertson, R.P., 1996. Insulin-secreting cell lines:

classification, characteristics and potential applications. Diabetes and

Metabolism 22, 7–14.

Polidori, M.C., Mecocci, P., Stahl, W., 2000. Plasma levels of

lipophilic antioxidants in very old patients with Type 2 diabetes.

Diabetes/Metabolism Research and Reviews 16, 15–19.

Polidori, M.C., Stahl, W., Eichler, O., Niestroj, I., Sies, H., 2001. Profiles of

anti-oxidants in human plasma. Free Radical Biology and Medicine 30,

456–462.

Portha, B., Picon, L., Rosselin, G., 1979. Chemical diabetes in the adult

rats as the spontaneous evolution of neonatal diabetes. Diabetologia 17,

371–377.

Potenza, M.A., Marasciulo, F.L., Tarquinio, M., Tiravanti, E., Colantuono,

G.,Federici, A., Kim, J.A., Quon, M.J., Montagnani, M., 2007. EGCG,

a green tea polyphenol, improves endothelial function and insulin

sensitivity, reduces blood pressure, and protects against myocardial I/R

injury in SHR. American Journal of Physiology - Endocrinology and

Metabolism 292(5), 1378–1387.

Poulsen, J. E. 1975. The impact of August Krogh on the insulin

treatment of diabetes and our present status. Acta medica scandinavica.

Supplementum 578, 7–14.

Prasanna, M., 2000. Hypolipidemic effect of fenugreek: a clinical study.

Indian Journal of Pharmacology 32, 34-36.

Prasannan, K., 1973. Glycogen levels in brain and liver of normal alloxan

diabetic and insulinized rats. Indian Journal of Experimental Biology 2,

331–332.

Price, K.D., Price, C.S., Reynolds, R.D., 2001.Hyperglycemia–induced

ascorbic acid deficiency promotes endothelial dysfunction and the

development of atherosclerosis. Atherosclerosis 158(1), 1–12.

Prince, P.S.M., Menon, V.P., Pari, L., 1997. Effect of Syzigium

cumini extracts on hepatic hexokinase and glucose–6–phosphatase in

experimental diabetes. Phytotherapy Research 11, 529–531.

Prince, P.S.M., Menon, V.P., 2000. Hypoglycemic and other related actions

of Tinospora cordifolia roots in alloxan– induced diabetic rats. Journal of

Ethnopharmacology 70, 9–15.

Priscilla, D.H., Prince, P.S., 2009. Cardioprotective effect of gallic acid on

cardiac troponin-T, cardiac marker enzymes, lipid peroxidation products

and antioxidants in experimentally induced myocardial infarction in

Wistar rats. Chemico-Biological Interactions 179(2–3), 118–124.

Puigserver, P., Wu, Z., Park, C.W., Graves, R., Wright, M., Spiegelman,

B.M., 1998. A cold-inducible coactivator of nuclear receptors linked to

adaptive thermogenesis. Cell 92, 829–839.

Punitha, R., Manoharan, S., 2006. Antihyperglycemic and

antilipidperoxidative effects of Pongamia pinnata (Linn.) Pierre flowers

in alloxan induced diabetic rats. Journal of Ethnopharmacology 105,

39–46.

Ragavan, B., Krishnakumari, S., 2006. Antidiabetic effect of T. arjuna

bark extract in alloxan induced diabetic rats. Indian Journal of Clinical

Biochemistry. 21(2), 123–128.

Rahman, I., MacNee, W., 2000. Oxidative stress and regulation of

glutathione in lung inflammation. European Respiratory Journal 16,

524–554.

Rajalakshmia, K., Devaraj, H., Niranjali Devaraj, S., 2001. Assessment

of the no–observed–adverse–effect level (NOAEL) of gallic acid in mice.

Food and Chemical Toxicology. 39(9) 919–922.

Rajani Kanth, V., Uma Maheswara Reddy, P., Raju, T.N., 2008. Attenuation

of streptozotocin-induced oxidative stress in hepatic and intestinal

tissues of Wistar rat by methanolic–garlic extract. Acta Diabetologica 45,

243–251.

Ram, A., Lauria, P., Gupta, R.P., Kumar, P., Pandsharma V.N.,

1997. Hypocholesterolemic effects of T. arjuna tree bark. Journal of

Ethnopharmacology 55, 165–169.

Rang, H.P., Dale, M.M., 1991. The Endocrine System Pharmacology, 2nd

edition, Longman, Harlow.

Rao, N.K., Nammi, S., 2006. Antidiabetic and renoprotective effects

of the chloroform extract of Terminalia chebula Retz. seeds in

streptozotocin–induced diabetic rats. BMC Complementary and

Alternative Medicine.6, 6–17.

Rao, R.M., Salem, F.A., Gleason-Jordan, I., 1998. Antidiabetic effects of

a dietary supplement pancreas tonic. Journal of the National Medical

Association 10, 614–618.

Rao, N.K., Srinavas, N., 2006. Antidiabetic and retinoprotective

effects of the chloroform extract of Terminalia chebula Retz. seeds

in streptozotocin-induced diabetic rats. BMC Complementary and

Alternative Medicine 6, 127–132.

Rasch, R., 1979. Prevention of diabetic glomerulopathy in streptozotocin

diabetic rats by insulin treatment Glomerular basement membrane

thickness. Diabetologia 16(5), 319–324.

Rasch, R., Mogensen, C.I., 1980. Urinary excretion of albumin and total

protein in normal and streptozotocin diabetic rats. Acta Endocrinology

95, 376–381.

Rasmussen, S.E., Frederiksen, H., Struntze Krogholm, K., Poulsen,

L., 2005. Dietary proanthocyanidins: occurrence, dietary intake,

bioavailability, and protection against cardiovascular disease., Molecular

Nutrition Food Research 49, 159–174.

Rau, O., Wurglics, M., Dingermann, T., Abdel-Tawab, M.,

Schubert-Zsilavecz, M., 2006. Screening of herbal extracts for activation

of the human peroxisome proliferator-activated receptor. Pharmazie 61,

952–956.

Reaven, G.M., 1988. Banting lecture: role of insulin resistance in human

disease. Diabetes 37, 1595–1607.

Reddy, T.N., Padmaja, C., Rao, J.V., Reddy, P.U., 1995. Modulatory effect

of Sepia shell extract on activity of glucose- 6- phosphatase and alanine

amino transferase in diabetic mice. Indian Journal of Experimental

Biology 33(11), 886–888.

Rees, D.A., Alcolado, J.C., 2005. Animal models of diabetes mellitus.

Diabetic Medicine 22, 359–370.

Reinhold, J. G., 1953. Manual determination of serum total protein,

albumin and globulin fractions by Biuret method. In: Standard Methods

in Clinical Chemistry. vol. 1, edited by M. Reiner, p. 88. Academic Press,

New York.

Reitman, S., Frankel, S. A., 1957. Colorimetric method for the

determination of serum glutamate oxaloacetic and glutamate pyruvic

transaminases. American Journal of Clinical Pathology 28(1), 56–63.

Roach, P.J., 2002. Glycogen and its metabolism. Current Molecular

Medicine 2, 101–120.

Robertson, R.P., Olson, L.K., Zhang, H.J., 1994. Differentiating glucose

toxicity from glucose desensitization: a new message from the insulin

gene. Diabetes 43, 1085-1089.

Robert M Silverstein, G. Clayton Baiseler and Terence C. Morrill, 1981.

Spectroscopic Identification of Organic Compounds, Fourth Edition

John-Wiley and Sons Inc., 321.

Roden, M.,Bernroider, E., 2003. Hepatic glucose metabolism in humans

its role in health and disease. Best Practice and Research Clinical

Endocrinology and Metabolism 17, 365–383.

Rohini Chaubal, Deshpande, V.H., Deshpande1, N.R., 2005. Methyl

gallate, the medicinally important compound: A Review. Electron.

Electronic Journal of Environmental, Agricultural and Food Chemistry

4(4), 956–962.

Roman-Ramos, R., Florez-Saenz, J.L., Alarcon-Aguilar, F.J., 1995.

Antihyperglycemic effect of some edible plants. Journal of

Ethnopharmacology 48, 25–32.

Rossetti, L., Giaccari, A., DeFronzo, R.A., 1990. Glucose toxicity. Diabetes

Care 13, 610–630.

Roth, R.A., Cassell, D.J., 1983. Insulin Receptor - Evidence that it is a

protein kinase. Science 219, 299–301.

Rotruck, J.T., Pope, A.L., Ganther, H.E., 1973. Selenium:biochemical role

as a component of glutathione peroxidase. Science 179, 588–590.

Row, L.R., Murty, P.S., 1970. Chemical examination of Terminalia bellerica

Roxb. Indian Journal of Chemistry 8, 1047–1048.

Sabu M.C., Kuttan R., 2002. Anti-diabetic activity of medicinal plants

and its relationship with their antioxidant property, Journal of

Ethnopharmacology 81 155–160.

Sabu M.C., Kuttan R., 2009. Antidiabetic and antioxidant activity of

Terminalia belerica Roxb. Indian Journal of Experimental Biology 47,

270–275.

Saito, T., Abe, D., Sekiya, K., 2008. Sakuranetin induces adipogenesis

of 3T3-L1 cells through enhanced expression of PPAR [gamma]2.

Biochemical and Biophysical Research Communications 372(4), 835–839.

Sajeeth, C.I., Manna, P.K., Manavalan, R., 2011. Antioxidant Activity

of Polyherbal Formulation on Streptozotocin Induced Diabetes in

Experimental Animals. Der Pharmacia Sinica 2 (2), 220–226.

Sale, E., Sale, G., 2008. Protein kinase B: signalling roles and therapeutic

targeting. Cellular and Molecular Life Sciences 65(1), 113–127.

Saltiel, A.R., Kahn, C.R., 2001. Insulin signalling and the regulation of

glucose and lipid metabolism, Nature. 414(6865), 799–806.

Sambrokk, J., Fritsch, E.F., Maniatis, T., 1989. In:Sambrook, J.,

Russel, W.D.(Eds.), Molecular Cloning-A, Laboratory Manual. thirded.,

ColdSpring Harbor Laboratory Press, Cold Spring Harbor, NewYork,

USA, 5.045.13.

Sameermahmood, Z., Raji, L., Saravanan, T., Vaidya, A., Mohan, V.,

Balasubramanyam, M., 2010. Gallic Acid Protects RINm5F β-cells from

Glucolipotoxicity by its Antiapoptotic and Insulin-secretagogue Actions,

Phytotherapy Research 24, S83–S94.

Samnegard B, Jacobson SH, Jaremko G, Johansson BL, Ekberg, K.,

Isaksson, B., Eriksson, L., Wahren, J., Sjoquist M., 2005. C-peptide

prevents glomerular hypertrophy and mesangial matrix expansion in

diabetic rats. Nephrology Dialysis Transplantation 20(3), 532–538.

Sandahl-Christiansen, J., Frandsen, M., Parving, H.H., 1981. The effect

of intravenous insulin infusion on kidney function in insulin-dependent

diabetes mellitus. Diabetologia 20, 199–204.

Sandler, S., Swenne, I., 1983. Streptozotocin, but not alloxan, induces DNA

repair synthesis in mouse pancreatic islets in vitro. Diabetologia 25,

444–447.

Sanjay, G., Tiku, A.K., Rana, S., 2010. Antioxidant activity of acetone

extract/fractions of Terminalia bellerica Roxb. fruit. Indian Journal of

Biochemistry and Biophysics 47(2), 110–116.

Saravanan, S., Srikumar, R., Manikandan, S., Jeya Parthasarathy, N.,

Sheela Devi, R., 2007. Hypolipidemic effect of triphala in experimentally

induced hypercholesteremic rats. Yakugaku Zasshi 127(2), 385–388.

Sassy-Prigent, C., Heudes, D., Jouquey, S., Auberval, D., Belair, M.F.,

Michel, O., Hamon, G., Bariety, J., Bruneval, P., 1995. Morphometric

detection of incipient glomerular lesions in diabetic nephropathy in rats.

Protective effects of ACE inhibition. Laboratory Investigation 73, 64–71.

Satoh, S., Nishimura, H., Clark, A.E., Kozka, I.J., Vannucci, S.J., Simpson,

I.A., Quon, M.J., Cushman, S.W., Holman, G.D., 1993. Use of bismannose

photolabel to elucidate insulin-regulated GLUT 4 subcellular trafficking

kinetics in rat adipose cells. Evidence that exocytosis is a critical site of

hormone action. Journal of Biological Chemistry 268, 17820–17829.

Saxena, S.C. and Yadav, R.S. 1983. A new plant extract to suppress the

population of yellow fever and dengue vector Aedes aegypti (Diptera:

Culicidae). Current Science 52, 713–715.

Scalbert, A., Manach, C., Morand, C., Rmsy, C., Jimnez, L., 2005. Dietary

polyphenols and the prevention of diseases. Critical Reviews in Food

Science and Nutrition 45, 287–306.

Schalin-Jntti, C., Yki-Jrvinen, H., Koranyi, L., Bourey, R., Lindstrm, J.,

Nikula-Ijs, P., Franssila-Kallunki, A., Groop, L.C., 1994. Effect of insulin

on GLUT 4 mRNA and protein concentrations in skeletal muscle of

patients with NIDDM and their first-degree relatives. Diabetologia 37(4),

401–407.

Scheen, A.J., 2003. Treatment of type 2 diabetes. Acta Clinica Belgica 58,

318–324.

Schmidt, A.M., Stern, D., 2000. A radical approach to the pathogenesis of

diabetic complications. Trends in Pharmacological Sciences 21, 367–369.

Scott, D., Fisher, A., 1935. The effect of zinc salts on the action of insulin.

Journal of Pharmacology and Experimental Therapeutics 55, 206.

Senthilkumar, G.P., Arulselvan, P., Sathishkumar, D., Subramanian,

S.P., 2006. Anti-Diabetic activity of fruits on Terminalia chebula on

Streptozotocin induced diabetic rats. Journal of Health Science 52,

281–289.

Senthilkumar, G.P., Subramanian, S.P., 2008. Biochemical studies on

the effect of Terminalia chebula on the levels of glycoproteins in

streptozotocin-induced experimental diabetes in rats. Journal of Applied

Biomedicine 6, 105–115.

Sesti, G., 2006. Pathophysiology of insulin resistance. Best Practice and

Research Clinical Endocrinology and Metabolism 20(4), 665–679.

Shafqat, J., Melles, E., Sigmundsson, K., Johansson, B.L., Ekberg, K.,

Alvelius, G., Henriksson, M., Johansson, J., Wahren, J., Jrnvall, H.,

2006. Proinsulin C–peptide elicits disaggregation of insulin resulting

in enhanced physiological insulin effects. Cellular and Molecular Life

Sciences 63(15), 1805–1811.

Shahidi, F., Naczk, M., 2004. Phenolic compounds in fruits and vegetables.

In: Phenolics in food and nutraceutical, CRC LLC, pp 131–156.

Shaila H.P., Udupa A.L., Udupa S.L., 1995. Preventive actions

of Terminalia bellerica in experimentally induced atherosclerosis,

International Journal of Cardiology 49, 101–106.

Shaila, H.P., Udupa, S.L., Udupa, A.L., 1997. Hypolipidemic effect of

Terminalia arjuna in cholesterol fed rabbits. Fitoterapia 68, 405–409.

Shaila, H.P., Udupa, S.L., Udupa, A.L., 1998. Hypolipidemic activity

of three indigenous drugs in experimentally induced atherosclerosis.

International Journal of Cardiology 67, 119-124.

Shaila, H.P., Udupa, S.L., Udupa, A.L., 2000. Hypocholesterolemic activity

in rats of different fractions from Terminalia arjuna. Pharmacy and

Pharmacology Communications 6, 327–330.

Shanmugasundaram, K.R., Panneerselvam, C., Samudram, P.,

Shanmugasundaram, E.R.B., 1981. The insulinotropic activity of

Gymnema sylvestre, R. Br. An Indian medical herb used in controlling

diabetes mellitus. Pharmacy and Pharmacology Communications 13(5),

475–486.

Shanmugasundaram, K.R., Panneerselvam, C., Samudram, P.,

Shanmugasundaram, E.R.B., 1983. Enzyme changes and glucose

utilization in diabetic rabbits: the effects of Gymnema sylvestre, R. Br.

Journal of Ethnopharmacology 7, 205–234.

Shanmugasundaram, E.R.B., Gopinath, K.L., Radha Shanmugasundaram,

K.R., Rajendran, V.M. 1990a. Possible regeneration of the islets of

Langerhans in streptozotocin-diabetic rats given Gymnema sylvestre leaf

extracts. Journal of Ethnopharmacology 30, 265–279.

Shanmugasundaram, E.R.B., Rajeswari, G., Baskaran, K., Rajesh Kumar,

B.R, Radha Shanmugasundaram, K., Kizar Ahmath B., 1990b. Use

of Gymnema sylvestre leaf extract in the control of blood glucose in

insulin-dependent diabetes mellitus. Journal of Ethnopharmacology 30,

281–294.

Sharma P.C., Yelne M.B., Dennis T.J., 2005. Database on medicinal plants

used in Ayurveda Vol. 3: 158–162.

Sharma, R. D., Raghuram, T. C., Rao, V. D., 1991. Hypolipidaemic effect of

fenugreek seeds. A clinical study. Phytotherapy Research 5, 145–147.

Sharma, S.B., Nasir, A., Prabhu, K.M., Murthy, P.S., Dev, G., 2003.

Hypoglycaemic and hypolipidemic effect of ethanolic extract of seeds

of Eugenia jambolana in alloxan-induced diabetic rabbits. Journal of

Ethnopharmacology 85, 201–206.

Shepherd, P.R., Kahn, B.B., 1999. Glucose transporters and insulin

action–implications for insulin resistance and diabetes mellitus. New

England Journal of Medicine 341(4), 248-257.

Shimizu, M., Kobayashi, Y., Suzuki, M., Satsu, H., Miyamoto, Y., 2000.

Regulation of intestinal glucose transport by tea catechins., Biofactors

13, 61–65.

Shin, K.H., Kang, S.S., Seo, E.A., Shin, S.W., 1995. Isolation of

aldose reductase inhibitors from the flowers of Chrysanthemum boreale.

Archives of Pharmacal Research 18, 65–68.

Shirwaikar, A., Rajendran, K., Dinesh Kumar, C., Ram Gopal Bodla.,

2004. Antidiabetic activity of aqueous leaf extract of Annona squamosa

in streptozotocin nicotinamide type 2 diabetic rats. Journal of

Ethnopharmacology 91, 171–175.

Siddiqui, H. N., 1963. Studies on Terminalia bellerica Roxb. effect on

bile secretion and pharmacodynamic properties. Indian Journal of

Pharmacology 25, 297–302.

Sidell, R.J., Cole, M.A., Draper, N.J., Desrois, M., Buckingham, R.E.,

Clarke, K., 2002. Thiazolidinedione treatment normalizes insulin

resistance and ischemic injury in the zucker Fatty rat heart. Diabetes

51, 1110–1117.

Sima, A.A., Zhang, W., Sugimoto, Henry D, Li Z, Wahren, Grunberger,

G., 2001. C-peptide prevents and improves chronic type 1 diabetic

polyneuropathy in the BB/Wor rat. Diabetologia 44, 889–897.

Simpson, R.W., Shaw, J.E., Zimmet, P.Z., 2003. The prevention of type 2

diabetes: life style change or pharmacotherapy. A challenge for the 21st

century. Diabetes Research and Clinical Practice 59, 165–180.

Singh, S.N.,, Vats, P., Suri, S., Shyam, R., Kumria, M.M., Ranganathan, S.,

Sridharan, K., 2001. Effect of an antidiabetic extract of Catharanthus

roseus on enzymic activities in streptozotocin induced diabetic rats.

Journal of Pharmacology 76(3), 269–277.

Sinha, A.K., 1972. Colorimetric assay of catalase. Analytical Biochemistry

47, 389–394.

Smith, G. D., Ciszak, E., Pangborn, W., 1996. A novel complex of a

phenolic derivative with insulin: Structural features related to the T↔R

transition. Protein Science 5, 1502–1511.

Soltani, N., M. Keshavarz and A.R. Dehpour, 2007. Effect of oral

magnesium sulfate administration on blood pressure and lipid profile

in streptozotocin diabetic rat. European Journal of Pharmacology 560,

201–205.

Soto, C., Mena, R., Luna, J., Cerbon, M., Larrieta, E., Vital, P., Uria, E.,

Sanchez, M., Recoba, R., Barron, H., Favari L., Lara, A., 2004. Silymarin

Induces Recovery of Pancreatic Function after Alloxan Damage in Rats.

Life Science 75(18), 2167–2180.

Sowmya, P., Rajyalakshmi, P., 1999. Hypocholesterolemic effect of

germinated fenugreek seeds in human subjects. Plant Foods for Human

Nutrition 53, 359–365.

Sozmen, E.Y., Sozmen, B., Delen, Y., Onat, T., Catalase/ superoxide

dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate

poor glycemic control. Archives of Medical Research 32, 283–287.

Spencer, J.P., Rice-Evans, C., Williams, R.J., 2003. Modulation of

pro-survival Akt/protein kinase B and ERK1/2 signaling cascades by

quercetin and its in vivo metabolites underlie their action on neuronal

viability., Journal of Biological Chemistry 278, 34783–34793.

Sridhar, S.B., Sheetal, U.D., Pai, M.R., Shastri, M.S., 2005. Preclinical

evaluation of the antidiabetic effect of Eugenia jambolana seed powder in

streptozotocin-diabetic rats. Brazilian Journal of Medical and Biological

Research 38, 463–468.

Srivastava, S. K., Awasthi, S., Wang, C., Bhatnagar, A., Awasthi, Y.

C., Ansari, M. H., 1996. Attenuation of 4-hydroxynonenal-induced

cataractogenesis in rat lens by butylated hydroxytoluene. Current Eye

Research 1996, 15,749–754.

Srivastava R.D., Dwivedi S., Sreenivasan K.K., Chandrashekhar C.N.,

1992. Cardiovascular effects of Terminalia species of plants, Indian

Drugs 29 144–149.

Staker, B.L., Feese, M.D., Cushman, M., Pommier, Y., Zembower, D.,

Stewart, L., Burgin, A.B., 2005. Structures of three classes of anticancer

agents bound to the human topoisomerase I-DNA covalent complex.

Journal of Medicinal Chemistry. 48(7), 2336-2345.

Stanely Mainzen Prince, P., Priscilla, H., Devika, P.T., 2009. Gallic acid

prevents lysosomal damage in isoproterenol induced cardiotoxicity in

Wistar rats. European Journal of Pharmacology 615(1–3), 139–143.

Stearns, S.B., Camillo, A.B., 1977. Structural and chemical alterations

associated with hepatic glycogen metabolism in genetically diabetic

and sterptozotocin induced diabetic mice. Laboratory Investigation 36,

180–187.

Steiner, D.F., King, J., 1964. Induced synthesis of hepatic uridine

diphosphate glucose-glycogen glucosyltransferase after administration

of insulin to alloxan diabetic rats. Journal of Biological Chemistry 239,

1292–1298.

Steiner, D.F., Oyer, P.E., 1967. The biosynthesis of insulin and a probable

precursor of insulin by a human islet cell adenoma. Proceedings of the

National Academy of Sciences of the United States 57(2), 473–480.

Steiner, D. F., James, D. E., 1992. Cellular and molecular biology of the beta

cell. Diabetologia 35, S41–S48.

Stern, M.P., 1999. On the need for outcome trials in preventive

pharmacology:Lessons from the recent experience with adverse drug

reactions. Diabetes Care 22, 844–845.

Stockham, S.L., Scott, M.A. 2002. Fundamentals of Veterinary Clinical

Pathology. Ames, Iowa State University Press, 434–459.

Stretton, A.O.W., 2002. The first sequence: Fred Sanger and insulin.

Genetics 162, 527–532.

Strobel, P., Allard, C., Perez-Acle, T., Calderon, R., Aldunate, R., Leighton,

F., 2005. Myricetin, quercetin and catechin-gallate inhibit glucose uptake

in isolated rat. Biochemical Journal 386, 471–478.

Stumvoll, M., Meyer, C., Mitrakou, A., Nadkarni, V., Gerich, J., 1997. Renal

glucose production and utilization: new aspects in humans. Diabetologia

40, 749–757.

Suchalatha, S., Shyamala Devi, C.S., 2004. Protective effect of

Terminalia chebula against experimental myocardial injury induced by

isoproterenol. Indian Journal of Experimental Biology 42(2),174–178.

Sugano, M., Yamato, H., Hayashi, T., Ochiai, H., kakuchi, J., Goto, S.,

Nishijima, F., Iino, N., Kazama, J.J., Takeuchi, T., Mokuda, O., Ishikawa,

T., okazaki, R., 2006. High-fat diet in low dose streptozotocin treated

hemi nephrectomized rats induced all features of human type 2 diabetic

nephropathy: a new rat model of diabetic nephropathy, Nutrition,

Metabolism and Cardiovascular Diseases 16(7), 477–484.

Suja, S.R., Latha, P.G., Pushpangandan, P., Rajasekharan, S., 2004.

Evaluation of hepatoprotective effects of Helmlnthostachys zeylanica (L.)

Hook against carbon tetrachloride induced liver damage in Wistar rats.

Journal of Ethnopharmacology 92, 61–66.

Suzuki, Y., Lyall, V., Biber, T. U. L., Ford, G. D., 1990. A modified technique

for the measurement of sulfhydryl groups oxidized by reactive oxygen

intermediates. Free Radical Biology and Medicine 9, 479–484.

Szkudelski, T., 2001. The mechanism of alloxan and streptozotocin action

in β-cells of the rat pancreas. Physiology Research 50, 536–546.

Tae Joung Ha, Ken–ichi Nihei, Isao Kubo, 2004. Lipoxygenase Inhibitory

Activity of Octyl Gallate. Journal of Agricultural and Food Chemistry

52(10), 3177–3181.

Takasu, N., Komiya, I., Asawa, T., Nagasawa, Y., Yamada, T.,

1991. Streptozotocin- and alloxan-induced H2O2 generation and DNA

fragmentation in pancreatic islets. H2O2 as mediator for DNA

fragmentation. Diabetes 40, 1141–1145.

Takii, H., Kometani, T., Nishimura, T., Nakae, T., Okada, S., Fushiki, T.,

2001. Antidiabetic effect of glycyrrhizin in genetically diabetic KK-Ay

mice. Biological and Pharmaceutical Bulletin 24(5), 484–487.

Tan, A.W., Nuttall, F.Q., 1976. Regulation of synthase phosphatase and

phosphorylase phosphatase in rat liver. Biochimica et Biophysica Acta

445(1), 118–130.

Tanaka, Y., Gleason, C. E., Tran, P. O. T., Harmon, J. S. and Robertson,

R. P., 1999. Prevention of glucose toxicity in HIT-T15 cells and Zucker

diabetic fatty rats by antioxidants. Proceedings of the National Academy

of Sciences of the United States 96, 10857–10862.

Tariq M., Hussain S.J., Asif M., Jahan M., 1977. Protective effect of

fruit extracts of Emblica officinalis (Gaertn) and Terminalia bellerica

(Roxb.) in experimental myocardial necrosis in rats, Indian Journal of

Experimental Biology 15, 485–486.

Tasduq SA, Singh K, Satti NK, Gupta DK, Suri KA, Johri RK., 2006.

Terminalia chebula (fruit) prevents liver toxicity caused by sub-chronic

administration of rifampicin, isoniazid and pyrazinamide in combination.

Human and Experimental Toxicology 25(3), 111–118.

Taskiman, M.R., 1987. Lipoprotein lipase in diabetes. Diabetes /

Metabolism Reviews 3, 551–570.

Tchobroutsky, G., 1978. Relation of diabetic control to development of micro

vascular complications. Diabetologia 15, 143–152.

Teare, J.P., Punchard, N.A., Powell, J.J., Lumb, P.J., Mitchell, W.D.,

Thompson, R.P., Automated spectrophotometric method for determining

oxidized and reduced glutathione in liver. Clinical Chemistry 39,

686–689.

Terra, X., Valls, J., Vitrac, X., Mrrillon, J.M., Arola, L., Ardvol, A., Blad, C.,

Fernandez-Larrea, J., Pujadas, G., Salvad, J., Blay, M., 2007. Grape-seed

procyanidins act as antiinflammatory agents in endotoxin-stimulated

RAW 264.7 macrophages by inhibiting NFkB signaling pathway. Journal

of Agricultural and Food Chemistry 55, 4357–4365.

Thakur C.P., Thakur B., Singh S., Sinha P.K., Sinha S.K., 1988. The

Ayurvedic medicines Haritaki, Amala and Bahira reduce cholesterol

induced atherosclerosis in rabbits, International Journal of Cardiology

21, 167–175.

Thong, F.S., Dugani, C.B., Klip, A., 2005. Turning signals on and off: GLUT

4 traffic in the insulin-signaling highway. Physiology 20, 271–284.

Thuraisingham, R.C., Nott, C.A., Dodd, S.M., Yaqoob, M.M., 2000.

Increased nitrotyrosine staining in kidneys from patients with diabetic

nephropathy. Kidney International 57, 1968–1972.

Tiedge, M., Lortz, S., Drinkgren, J. and Lenzens, S., Relation between

antioxidant enzyme gene expression and antioxidant defense status of

insulin producing cells. Diabetes, 1997, 46, 1733–1742.

Tilg, H., Moschen, A.R., 2008. Inflammatory mechanisms in the regulation

of insulin resistance. Molecular Medicine 14(3–4), 222–231.

Tirgar, P.R., Shah, K.V., Patel, V.P., Desai, T.R., Goyal R.K., 2010.

Investigation into mechanism of action of anti–diabetic activity of

Emblica officinalis on streptozotocin induced type I diabetic rat. Research

Journal of Pharmaceutical, Biological and Chemical Sciences 1(4),

673–682.

Tiwari, A.K., Gode, J.D., Dubey, G.P., 1989. Effect of T.arjuna bark powder

on serum lipids and lipoproteins in hypercholesterolemic rabbits. Indian

Drugs 26, 664–667.

Tiwari, A. K., Madhusudana, R.J., 2002. Diabetes mellitus and multiple

therapeutic approaches of phytochemicals: present status and future

prospects. Current Science 83, 30-38.

Travlos, G.S.,Morris, R.W., Elwell, M.R., Duke, A., Rosenblum, S.,

Thompson, M.B., 1996. Frequency and relationship of clinical chemistry

and liver and kidney histopathology findings in 13 week toxicity studies

in rats. Toxicology 107, 17–29.

Trinder, P., 1969. Determination of glucose in blood using glucose oxidase

with an alternative oxygen acceptor, Annals of Clinical Biochemistry 6,

24-27.

Trivedi, V.P., Nesamany, S., Sharma, V. K., 1979. A clinical study of

the anti-tussive and anti–asthmatic effects of Vibhitakphal Churna

(Terminalia bellerica Roxb.) in the cases of Kasa-Swasa. Journal of

Research in Ayurveda and Siddha 3, 1–8.

Tulloch, P., Lawrence, L., McKern, N., Robinson, C., Bentley, J., Cosgrove,

L., Ivancic, N., Lovrecz, G., Siddle, K., Ward, C., 1999. Single-molecule

imaging of human insulin receptor ectodomain and its Fab complexes.

Journal of Structural Biology 125, 11–18.

Turk, J., Corbett, J.A., Ramanadham, S., Bohrer, A., McDaniel, M.L.,

1993. Biochemical evidence for nitric oxide formation from streptozotocin

in isolated pancreatic islets. Biochemical and Biophysical Research

Communications 197, 1458–1464.

Ueda, M., Nishiumi, S., Nagayasu, H., Fukuda, I., Yoshida, K.I., Ashida, H.,

2008. Epigallocatechin gallate promotes GLUT 4 translocation in skeletal

muscle. Biochemical and Biophysical Research Communications 377(1),

286–290.

UK Prospective Diabetes Study (UKPDS) Group, 1998. Intensive

blood-glucose control with sulphonylureas or insulin compared with

conventional treatment and risk of complications in patients with type

2 diabetes. UKPDS 33, Lancet 352, 837–851.

Ullrich, A., Bell, J.R., Chen, E.Y., Herrera, R., Petruzzelli, L.M., Dull, T.J.,

Gray, A., Coussens, L., Liao, Y.C., Tsubokawa, M., Mason, A., Seeburg,

P.H., Grunfeld, C., Rosen, O.M., Ramachandran, J., 1985. Human insulin

receptor and its relationship to the tyrosine kinase family of oncogenes.

Nature 313, 756–761.

Vadlamudi, R.V.S.V., Rodgers, R.L., McNeill, J.H., 1982. The effect of

chronic alloxan- and streptozotocin-induced diabetes on isolated rat heart

performance. Canadian Journal of Physiology and Pharmacology 60,

902–911.

Valabhji, J., Mc Coll, A. J., Richmond, W., Schachter, M.,Rubens, M. B.

and Elkeles, R. S., 2001. Total antioxidant status and coronary artery

calcification in type 1 diabetes. Diabetes Care 24, 1608–1613.

Valsa, P. K., Sudheesh, S., Vijayalakshmi, N. R., 1997. Effect of catechin on

carbohydrate metabolism. Indian Journal of Biochemistry and Biophysics

43, 406–408.

Valsaraj R., Pushpangadan P., Smitt U.W., Adsersen A., Christensen S.B.,

Sittie A., Nyman U., Nielsen C., Olsen C.E., 1997. New anti-HIV-1,

antimalarial, and antifungal compounds from Terminalia bellerica,

Journal of Natural Products 60, 739–742.

Van Dam, P.S., Van Asbeck, B.S., Erkelens, D.W., Marx, J.J.M., Gispen,

W.H. and Bravenboer, B., 1995. The role of oxidative stress in neuropathy

and other diabetic complications. Diabetes Metabolism Reviews 11,

181–192.

Vats, V., Yadav, S.P., Grover, J.K., 2003. Effect of T. foenumgraecum

on glycogen content of tissues and the key enzymes of carbohydrate

metabolism. Jounal of Ethnopharmacology 85, 237–242.

Vats, V., Yadav, S.P., Grover, J.K., 2004. Ethanolic extract of Ocimum

sanctum leaves partially attenuates streptozotocin-induced alterations

in glycogen content and carbohydrate metabolism in rats. Jounal of

Ethnopharmacology 90, 155–160.

Vedavanam, K., Srijayanta, S., O’Reilly, J., Raman, A., Wiseman,

H., 1999. Antioxidant action and potential antidiabetic properties

of an isoflavonoid-containing soyabean phytochemical extract (SPE).

Phytotherapy Research 13, 601–608.

Venkatachalam, C. M., Jiang, X., Oldfield, T., Waldman, M., 2003.

LigandFit: a novel method for the shape-directed rapid docking of ligands

to protein active sites. Journal of Molecular Graphics and Modelling 21,

289-307.

Vijaya, C.L., Anita, P., Naresh, C., 2010. Antioxidant availabiltiy

beheda (Terminalia bellerica (Roxb.)) in relation to its medicinal uses.

Pharmacognosy 2(10), 338–344.

Vinson, J.A., Teufel, K., Wu, N., 2001. Red wine, dealcoholized red wine,

and especially grape juice, inhibit atherosclerosis in a hamster model.

Atherosclerosis 156, 67–72.

Violet Kasabri, Peter R. Flatt, Yasser H.A. Abdel-Waha, 2010. Terminalia

bellerica stimulates the secretion and action of insulin and inhibits starch

digestion and protein glycation in vitro, British Journal of Nutrition 103

212–217.

Vishnu Prasad, C.N., Anjana, T., Asoke Banerji, Anilkumar

Gopalakrishnapillai, 2010. Gallic acid induces GLUT 4 translocation and

glucose uptake activity in 3T3-L1 cells, FEBS Letters 584, 531–536.

Vuong, T., Matineau, L.C., Ramassamy, C., Matar, C., Haddad, P.S., 2007.

Fermented Canadian lowbush blueberry juice stimulates glucose uptake

and AMP-activated protein kinase in insulin-sensitive cultured muscle

cells and adipocytes. Canadian Journal of Physiology and Pharmacology

85, 956–965.

Wang, P.H., Tsai, M.J., Hsu,C.Y., Hsu, H.K., Weng, C.F., 2008. Toona

sinensis Roem (Meliaceae) leaf extract alleviates hyperglycemia via

altering adipose glucose transporter 4, Food and Chemical Toxicology 46,

2554–2560.

Wang, B.J., Liu, C.T., Tseng, C.Y., Wu, C.P., Yu, Z.R., 2004. Hepatoprotective

and antioxidant effects of Bupleurum Kaoi Liu. (Chaoet Chuang) and

its fractions fractionated using supercortical CO2 on CCl4 induced liver

damage. Food and Chemical Toxicology 42, 60–617.

Wansi, J.D., Lallemand, M.C., Chiozem, D.D., Toze, F.A.A., Mbaze, L.M.,

Naharkhan, S., Iqbal, M.C., Tillequin, F., Wandji, J., Fomum, Z.T., 2007.

α-Glucosidase inhibitory constituents from stem bark of Terminalia

superba(Combretaceae) Phytochemistry 68, 2096–2100.

Ward, C., Lawrence, M., Streltsov, V., Garrett, T., McKern, N., Lou, M.,

Lovrecz, G., Adams, T., 2008. Structural insights into ligand-induced

activation of the insulin receptor. Acta Physiologica 192, 3–9.

Ward, C. W., Lawrence, M.C., 2009. Ligand-induced activation of the insulin

receptor: a multi-step process involving structural changes in both the

ligand and the receptor. BioEssays 31, 422–434.

Watson, R.T., Kanzaki, M. and Pessin, J.E., 2004. Regulated membrane

trafficking of the insulin-responsive glucose transporter 4 in adipocytes.

Endocrine Reviews 25, 177–204.

Wehroli, F. W., Marchand, A. P., Wehrli, S., 1989. Interpretation of Carbon

- 13 NMR spectra. Second Edition. John Wiley and Sons Inc.

Welsh, C.A., Lachance, P.A., Wasserman, B.P., 1989. Dietary phenolic

compounds: inhibition of Na+-dependent D-glucose uptake in rat

intestinal brush border membrane vesicles. Journal of Nutrition 119,

1698–1704.

West, E., Simon, O.R., Morrison, E.Y., 1996. Streptozotocin alters

pancreatic beta-cell responsiveness to glucose within six hours of

injection into rats. West Indian Medical Journal 45, 60–62.

WHO-World Health Organization 1980. Second report of the WHO expert

committee on diabetes mellitus. Technical Report Series 646–666.

WHO-World Health Organization 2003. Report of the Expert Committee on

the Diagnosis and Classification of Diabetes Mellitus, Diabetes Care 26,

January 2003.

WHO-World Health Organization 2006. Fact Sheet No. 138: Diabetes

mellitus. Available: http:// www.who.int/ mediacentre/factsheets/

fs312/en/html.nAccessed May 2, 2006.

White, J.R., 1996. The pharmacologic management of patients with type

II diabetes mellitus in the era of new oral agents and insulin analogs.

Diabetes Spectrum 9, 227–234.

White, M.F., 2003. Insulin Signaling in Health and Disease. Science

302(5651), 1710–1711.

Whitton, P.D., Hems, D.A., 1975. Glycogen synthesis in the perfused liver

of streptozotocin–diabetic rats. Biochemical Journal 150, 153–165.

Wild, S., Roglic, G., Green, A., Sicree, R., King, H., , 2004. Global prevalence

of diabetes: Estimates for year 2000 and projections for 2030. Diabetes

Care 27, 1047–1053.

William Kemp, 1986. NMR in Chemistry, A multinuclear introduction.

Macmillan Education Ltd.

Williams, R.J., Spencer, J.P., Rice-Evans, C., 2004. Flavonoids: antioxidants

or signaling molecules?, Free Radical Biology and Medicine 36, 838–849.

Willson T.M., Lambert M.H., Kliewer S.A. 2001. Peroxisome

proliferator-activated receptor gamma and metabolic disease. Annual

Review of Biochemistry 70, 341–367.

Wilson, R.L. 1998. Free radicals and tissue damage, mechanistic evidence

from radiation studies. In: Biochemical Mechanisms of Liver Injury.

Academic Press, NewYork, 123–125.

Witters, L.A., Auruch, J., 1978. Insulin regulation of hepatic glycogen

synthetase and phosphorylase, Biochemistry 17(3), 406–410.

Wolff, S. P., Dean, R. T., 1987. Glucose autoxidation and protein

modification, Biochemical Journal 245, 243–250.

Wolfram, S., Raederstorff, D., Preller, M., Wang, Y., Teixeira, S.R., Riegger,

C.,Weber, P., 2006. Epigallocatechin Gallate Supplementation Alleviates

Diabetes in Rodents. Journal of Nutrition 136(10), 2512–2518.

Wollheim, C.B., Sharp, G.W.G., 1981. The regulation of insulin release by

calcium. Physiological Reviews 61, 914–973.

Wu, L.Y., Juan, C.C., Hwang, L., Hsu, Y.P., Ho, P.H., Ho, L.T., 2004. Green

tea supplementation ameliorates insulin resistance and increases glucose

transporter IV content in a fructose-fed rat model. European Journal of

Nutrition 43(2), 116–124.

Wu, Z., Xie, Y., Morrison, R.F., Bucher, N.L., Farmer, S.R., 1998. PPAR

gamma induces the insulin-dependent glucose transporter GLUT 4 in

the absence of C/EBPalpha during the conversion of 3T3 fibroblasts into

adipocytes. Journal of Clinical Investigation 101, 22–32.

Wu, H., Guo, H., Zhao, R., 2006. Effect of Lycium barbarum polysaccharide

on the improvement of antioxidant ability and DNA damage in NIDDM

rats. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan

126, 365–371.

Xia, M., Laychock, S.G., 1993. Insulin secretion, myo-inositol transport, and

Na(+)-K(+)-ATPase in glucose–desensitized rat islets. Diabetes 42(10),

1391–1400.

Xiu, L.M., Miura, A.B., Yamamoto, K., Kobayashi, T., Song, Q.H.,

Kitamura,H., Cyong, J.C., 2001. Pancreatic islet regeneration by

ephedrine in mice with streptozotocin-induced diabetes. American

Journal of Chinese Medicine 29, 493–500.

Yadava, R.N., Rathore, K., 2001. A new cardenolide from the seeds of

Terminalia bellerica. Fitoterapia 72, 310–312.

Yang, Liu., Zhao, Chun-Yan., Liu, Ying-Qian., 2011. Synthesis

and biological evaluation of novel conjugates of camptothecin and

5-flurouracil as cytotoxic agents. Journal of Brazilian Chemical Society

22(2), 308-318.

Yanjnik, C.S., 2001. The insulin resistance epidemic in India: fetal origins,

later lifestyle, or both? Nutrition Review 59, 1–9.

Yeh, G.Y., Eisenberg, D.M., Kaptcuk, T.J., Philips, R.S., 2003. System

review of herbs and dietary supplements for glycemic control in diabetes.

Diabetes Care 26(4), 1277–1294.

Yoshikawa, M., Shimada, H., Nishida, N., Li, Y., Toguchida, I., Yamahara,

J. and Matsuda, H., 1998. Antidiabetic principles of natural medicines. II.

Aldose reductase and alpha-glucosidase inhibitors from Brazilian natural

medicine, the leaves of Myrcia multiflora DC. (Myrtaceae): structures of

myrciacitrins I and II and myrciaphenones A and B. Chem. Pharm. Bull.,

46, 113–119.

Zanatta, L., Rosso, A., Folador, P., Figueiredo, M.S., Pizzolatti, M.G.,

Leite, L.D., Silva, F.R., 2008. Insulinomimetic Effect of Kaempferol

3-Neohesperidoside on the Rat Soleus Muscle. Journal of Natural

Products 71(4), 532–535.

Zavaroni, I., Bonara, E., Pagilora, M., 1989. Risk factors for coronary artery

disease in healthy persons with hyperinsulinemia and normal glucose

tolerance. New England Journal of Medicine 320, 702–705.

Zhang, H.M., Chen, S.W., Zhang, L.S., Feng, X.F., 2008. The effects of soy

isoflavone on insulin sensitivity and adipocytokines in insulin resistant

rats administered with high-fat diet. Natural Product Research 22(18),

1637–1649.

Zhao, Y.F., Keating, D.J., Hernandez, M., Feng, D.D., Zhu, Y., Chen,

C., 2005. Long-term inhibition of protein tyrosine kinase impairs

electrophysiologic activity and a rapid component of exocytosis in

pancreatic β-cells. Journal of Molecular Endocrinology 35, 49–59.

Zhao, R., Li, Q., Xiao, B., 2005b. Effect of Lycium barbarum polysaccharide

on the improvement of insulin resistance in NIDDM rats. Yakugaku

Zasshi: Journal of the Pharmaceutical Society of Japan 125, 981–988.

Zhongbing Lu, Guangjun Nie, Peter S. Belton, Huiru Tang , Baolu Zhao,

2006. Structure activity relationship analysis of antioxidant ability

and neuroprotective effect of gallic acid derivatives. Neurochemistry

International 48, 263-274.

Zierath, J.R., Galuska, D., Johansson, B.L., Wallberg-Henriksson, H., 1991.

Effect of human C-peptide in glucose transport in in vitro incubated

human skeletal muscle. Diabetologia 34, 899–901.

Zisman, A., Peroni, O.D., Abel, E.D., Michael, M.D., Mauvais-Jarvis,

F., Lowell, B.B., Wojtaszewski, J.F., Hirshman, M.F., Virkamaki, A.,

Goodyear, L.J., Kahn, C.R., Kahn, B.B., 2000. Targeted disruption of the

glucose transporter 4 selectively in muscle causes insulin resistance and

glucose intolerance. Nature Medicine 6, 924–928.

PUBLICATIONS

1. R. Cecily Rosemary Latha, P. Daisy, 2011. Insulin-secretagogue,

antihyperlipidemic and other protective effects of gallic acid isolated

from Terminalia bellerica Roxb. in streptozotocin-induced diabetic

rats. Chemico-Biological Interactions 189, 112-118.

(Impact factor: 2.457).

2. Latha, R.C.R., Daisy, 2010. Influence of Terminalia bellerica Roxb.

fruit extracts on biochemical parameters in streptozotocin diabetic

rats. International Journal of Pharmacology 6, 89-96.

3. R. Cecily Rosemary Latha and P Daisy P, 2008. Effect of Costus

pictus D. Don in streptozotocin induced diabetic rats. Biochemical

and Cellular Archives, 8(2), 173-178.

4. Daisy, P., Rajalakshmi, M., Suveena, S., Lilly, V., Latha, R.C.R., 2011.

Ligand based Virtual screening on natural compounds for discovering

active ligands. Der Pharma Chemica Volume 3 issue 3.